









A Prospective Cohort Study and 
Evaluation of an End-of-life 
Programme Intervention in a Primary 
Health Care Setting 
By 
Jennifer Mary Morgan 
MRGJEN002 
Submitted to the University of Cape Town
In partial fulfillment of the requirements for the degree
MMed Family Medicine
Faculty of Health Sciences
UNIVERSITY OF CAPE TOWN
Date of submission:  1 July 2014
Supervisors: 
Elizabeth Gywther 
School of Public Health and Family Medicine 
University of Cape Town 
Abdul Isaacs  
School of Public Health and Family Medicine 
University of Cape Town 
The copyright of this thesis vests in the author. No 
quotation from it or information derived from it is to be 
published without full acknowledgement of the source. 
The thesis is to be used for private study or non-
commercial research purposes only. 
Published by the University of Cape Town (UCT) in terms 












There are a number of people I would like to thank, for their help, support and 
encouragement throughout this research. 
To my husband, my anchor, for your patience, support and sound reasoning.  And 
practically, for your thorough editing. 
To my parents for believing in me and introducing me to palliative care at a young age. 
To my extended family, for patience and understanding. 
To my supervisors, Liz and Abdul, for the many hours of work and assistance in directing 
my thoughts. 
To Rene for helping to get me started and keeping things in perspective. 
To Sue and Cath for proofreading. 
To Yvonne for her work as research assistant, her kind but firm approach and great empathy 
for our participants. 
To the people of Mitchell’s Plain who agreed to be a part of this study and especially for 
those who got involved and taught me so much. 
To Grandpa and Uncle Carl, following in your footsteps is an honour. 
II 
DECLARATION 
I, Jennifer Mary Morgan hereby declare that the work on which this thesis is based is my 
original work (except where acknowledgements indicate otherwise) and that neither the 
whole work nor any part of it has been, is being, or is to be submitted for another degree in 
this or any other university. 
I empower the university to reproduce for the purpose of research either the whole or any 
portion of the contents in any manner whatsoever. 
Signature:     
Date:   1 July 2014 
Signature removed
III 
TABLE OF CONTENTS 
CHAPTER 1: INTRODUCTION……………………………………………………..…….1 
CHAPTER 2: LITERATURE REVIEW ………………………………………………….. 11 
RATIONALE FOR RESEARCH…………………………………………….…….25 
AIMS AND OBJECTIVES………………………………………………….……..26 
CHAPTER 3: METHODS…………………………………….…………………………….27 
CHAPTER 4: RESULTS……………………………………………………………………39 
CHAPTER 5: DISCUSSION………………………………………………………………..64 





ACD – Advanced Care Directive 
AIDS – Acquired Immunodeficiency Syndrome 
APCA – African Palliative Care Association 
APCA African POS – African Palliative Care Association African Palliative Outcome Scale 
ARV - Antiretroviral 
CHC – Community Health Centre 
CNP – Clinical Nurse Practitioner 
COPD – Chronic Obstructive Pulmonary Disease 
CVA – Cerebro-vascular Accident 
DOTs – Directly Observed Treatment 
EN – Enrolled Nurse 
ENA – Enrolled Nursing Assistant 
GFJ – GF Jooste Hospital 
GPs – General Practitioners 
GSF – Gold Standards Framework 
GSH – Groote Schuur Hospital 
HBC – Home Based Carers 
HIV – Human Immunodeficiency Virus 
HIV/AIDS – Human Immunodeficiency Virus / Acquired Immunodeficiency Syndrome 
HPCA – Hospice Palliative Care Association of South Africa 
HPO – Health Promotion Officer  
IHD – Ischemic Heart Disease 
IOELC – International Observatory on End of Life Care 
KS – Kaposi’s Sarcoma 
LRTI – Lower Respiratory Tract Infection 
MPCHC – Mitchells Plain Community Health Centre 
V 
MPDH – Mitchells Plain District Hospital 
MDHS – Metro District Health Service 
MVA – Motor Vehicle Accident 
NCDs – Non-communicable Diseases 
NGOs – Non-governmental Organisations 
NHS – National Health Service 
RN – Registered Nurse 
SMS – Short Message Service 
TB – Tuberculosis 
UNAIDS – United Nations Programme on HIV/AIDS 
WHO – World Health Organisation 
VI 
FIGURES 
Figure 1: Schematic representation of study programme timeline. 
Figure 2: APCA African POS responses at week zero (entire cohort) 
Figure 3: APCA African POS responses at week zero, for participants who survived the 
study compared with participants who died during the study 
Figure 4: Comparison of APCA African POS responses by different disease categories 
Figure 5: Participants who attended the doctor’s consultation, week zero compared to the 
visit after the consultation. 
Figure 6: Ways in which the co-ordinator assisted participants 
Figure 7: Responses to questions about the visit to the doctor 
Figure 8: Responses to what aspects of the support group the participants felt were helpful 
VII 
TABLES 
Table 1: Demographic Characteristics of Participants 
Table 2: Demographic Characteristics of Caregivers by Gender 
Table 3: Recent Admissions to Hospital 
Table 4: Recent Visits to the Emergency Unit 
Table 5: Recent Visits to the CHC 
Table 6: Visits to the MPCHC After Recruitment to the Programme 
Table 7: Demographics of Group A and Group B 
Table 8: Comparison of patients who died before three completed weeks and those who died 
after three completed weeks 
Table 9: Statistics represented in Figure 2 
Table 10: Statistics represented in Figure 3 
Table 11: Statistics represented in Figure 4 
Table 12: Statistics represented in Figure 5 
Table 13: Job categories of staff respondents for the staff evaluation 
Table 14: Staff response to questions on knowledge of the programme 
Table 15: Ways staff members were involved in the programme 
Table 16: Staff response to if they had referred a patient to the programme or not 
Table 17: Staff response to knowledge of which patients to refer to the programme 
Table 18: Staff responses to barriers in referring patients to the programme 
Table 19: Staff responses to having met the programme co-ordinator or not 
Table 20: Staff response to asking the coordinator to assist with patient care, of patients not 
necessarily in the programme 
Table 21: Staff response to the question of degree of impact the programme had on them 
Table 22: Staff response to the question of degree of impact the programme had on them 
(broken into staff categories)  
Table 23: Staff responses to being more involved in the programme, if it were to continue 
Table 24: Staff responses to getting more information 




Context:  Palliative care is the holistic care for patients, and their families, who are facing 
the end of their life due to a life-threatening illness.  The Global burden of disease indicates 
that 65.5% of all deaths in 2010 were caused by non-communicable diseases.   In South 
Africa, seven of the top ten causes of death in 2007 would benefit from palliative care. 
Objectives:  This study aimed to evaluate patient reported outcomes at a Community Health 
Centre (CHC) prior to an intervention and to evaluate the impact of an intervention involving 
a support group and focused care for people facing life threatening illness.   
Method:  This study was conducted in a primary health care clinic, over a period of six 
months.  Initially the participants were recruited, by the programme coordinator, to a control 
group (Group A) and the African Palliative Care Association African Palliative Outcome 
Scale (APCA African POS) was applied to them weekly for six weeks.  Thereafter the 
intervention began, consisting of a support group and an in-depth consultation with a doctor 
at the clinic.  The intervention group (Group B) was recruited after the completion of Group 
A’s data collection.  Group B, like Group A, were asked to complete the APCA African POS 
questions, weekly for six weeks.  Group A and Group B were invited to participate in the 
intervention.  The participants still involved in the intervention at the completion of the 
study, and the staff at the CHC, completed an evaluation of the intervention. 
Results: There were 46 participants recruited to the study, five participants were excluded as 
they were not mentally competent; 20 participants were recruited to Group A and 21 
participants were recruited to Group B.  The percentage of participants in the whole cohort 
who died was 43.9%, with 66.7% of Group B dying at some point in the study.  All (100%) 
participants wanted the role of programme coordinator to continue, the support group to 
continue to meet, monthly and the programme to continue with few changes.  Of the staff 
that completed the evaluation, 64.9% had referred patients to the study, 66.67% stated that 
the study had a positive impact on them as staff members and 96.9% stated that they wanted 
the programme to continue.  
Conclusion: The participant and staff evaluation showed that both parties found the 
programme beneficial and recommended that the programme continue, with few changes.  
However, due to the attrition rate and poor participation in the intervention among Group B 
participants, the APCA African POS results could not be used to show a change in patient 
reported outcomes.  Recommendations include: a permanent palliative care programme, a 
study over a longer period of time, active reminders to refer patients to the programme 
timeously, palliative care training for the staff in the facility and more opportunities for staff 
to be more involved in future palliative care programmes within the clinic. 
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CHAPTER 1: INTRODUCTION 
Health is defined as a state of complete physical, mental and social well-being and not 
merely the absence of disease or infirmity1.  If we desire holistic health care, we should aim 
for this ideal, despite the disease entities our patients may face.  When considering patients 
who are nearing the end of their life as a result of chronic illness, although cure may not be 
possible, we as health care providers can still attempt to improve physical, mental and social 
wellbeing.  This is the essence of palliative care2.   
The aim of this study was to evaluate patient reported outcomes at a Community Health 
Centre, in Cape Town, South Africa, prior to an intervention and then to evaluate the impact 
of an intervention, involving a support group and focused care, for people facing life 
threatening illnesses.  We aimed to achieve this by meeting the following set of objectives. 
We planned to determine the prevalence of people with palliative care needs at Mitchells 
Plain Community Health Centre (MPCHC) and to assess the extent to which people with 
life-threatening illnesses seek medical attention prior to an intervention.  We planned to 
assess the physical, psychological and spiritual concerns of people facing life-threatening 
illnesses, prior to an intervention and then to determine if there is a change in these patient 
reported outcomes with a palliative care programme in place.  We planned to evaluate the 
effect of the programme on the participants and the staff of the MPCHC. 
 
Palliative Care: 
There are two main definitions of palliative care, one from the World Health Organisation 
(WHO) and the other from the European Palliative Care Association.  Both encompass the 
principles of palliative care. 
The WHO broadly defines palliative care as care that improves quality of life for patients 
and their families, who face the difficulties associated with life-threatening illness. This care 
includes pain and symptom control, as well as spiritual and psychological support. Beyond 
defining palliative care, the WHO recommends that: (a) all governments include palliative 
care in their primary health care policy development and (b) they integrate palliative care 
programmes into existing health care systems.2 
According to the European Palliative Care Association, ‘Palliative care is the active, total 
care of the patients whose disease is not responsive to curative treatment. Control of pain, of 
other symptoms, and of social, psychological and spiritual problems is paramount.  Palliative 
care is interdisciplinary in its approach and encompasses the patient, the family and the 
community in its scope. In a sense, palliative care is to offer the most basic concept of care – 
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that of providing for the needs of the patient wherever he or she is cared for, either at home 
or in the hospital.  Palliative care affirms life and regards dying as a normal process; it 
neither hastens nor postpones death. It sets out to preserve the best possible quality of life 
until death.’3 
While these definitions provide a clear explanation of palliative care, there are issues they do 
not address, for example, expanding on how important palliative care is and how many 
people would benefit from such health care. 
 
Disease Burden and Palliative Care: 
People who are dying from progressing chronic illnesses need care that is different to 
preventative primary health care therapy, because it is too late to prevent the illness. More 
emphasis needs to be placed on helping the person to accept their limitations (including the 
shortening of their life), facilitating communication with their family and assisting them to 
achieve spiritual wellbeing.  Such patients specifically need palliative care (individualised to 
each patient), which is supportive in nature and seeks to improve quality of life and control 
symptoms.  
The global and local burden of disease gives an indication of the scope of need for palliative 
care.  The WHO Global Burden of Disease report from 2012 indicates that non-
communicable diseases are the leading cause of death internationally, at 65.5% of all deaths 
in 20104. In the report, the top 10 causes of death, globally were, in order of prevalence (with 
rates per 100 000 deaths given), ischemic heart disease (IHD, 105.7), cerebro-vascular 
diseases (88.4), chronic obstructive pulmonary disease (COPD, 43.8), lower respiratory tract 
infections (LRTI, 40.0), lung cancer (23.4), HIV/AIDS (21.4), diarrheal disease (20.9), 
motor vehicle accidents (MVA, 19.5), diabetes (19.5) and tuberculosis (TB; 18.0) 4. Of these 
causes of death, IHD, cerebro-vascular diseases, COPD, lung cancer, HIV/AIDS and 
diabetes are considered to be chronic diseases, for which palliative care can be used and 
improve people’s quality of life.  These data suggest that, internationally, there is thus a need 
for palliative care.  
Sub-Saharan Africa has been devastated by the HIV (Human Immunodeficiency Virus) 
epidemic5.  According to the Global Burden of Disease report, Southern sub-Saharan Africa 
has the top five causes of years of life lost as:  HIV/AIDS, LRTI, diarrheal diseases, 
interpersonal violence and TB4. In seventh place is cerebro-vascular disease and in eighth 
place is diabetes mellitus4.  HIV/AIDS continues to be a major burden of disease for sub-
Saharan Africa. In 2012 the UNAIDS (United Nations Programmes on HIV/AIDS) report 
estimated that world-wide there are approximately 34 million people living with HIV6. In 
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sub-Saharan Africa the prevalence of HIV is 4.9%, with 69% of the world’s HIV-infected 
people living in the area6.   
In South Africa the leading cause of death in 2007 was pulmonary TB7.  The other nine 
causes that constituted the top ten causes of death in the 2007 report are: LRTI, diarrhoeal 
disease, HIV/AIDS, cerebro-vascular disease, diabetes mellitus, trauma, heart failure, 
hypertension and IHD7.  Of the top ten causes of death in South Africa, seven would benefit 
from palliative care: TB, HIV/AIDS, cerebro-vascular disease, diabetes mellitus, heart 
failure, hypertension and IHD7.   
Much emphasis is placed on screening for chronic illnesses, as well as diagnosis and 
prevention of complications from chronic illnesses.  However, once a person has a chronic 
illness and especially once they have irreversible complications, action must take place to 
provide care for them.  This action should not be aimed at prolonging suffering, but rather at 
alleviating suffering from illness, and this should include appropriate pain management.  
This care needs to include preparation for the future: biologically, psychologically and 
socially.  And so this indicates a need for palliative care, with broad inclusion criteria, 
providing care for all members of the community, and their families, who are facing life-
threatening illnesses.  
In the Western Cape, in 2009, HIV was the leading cause of death, followed by TB, IHD, 
cerebro-vascular disease, diabetes mellitus, interpersonal violence, lung cancer, LRTI, 
COPD and hypertensive heart disease8. In Mitchells Plain, a sub-district of Cape Town, 
where this study took place, the causes of death were very similar to that of the Western 
Cape, with a few differences.  The causes of death, in Mitchells Plain, in 2006 were: 
homicide, HIV, TB, road traffic accidents, LRTI, diabetes mellitus, low birth weight, 
diarrheal diseases, IHD and cerebro-vascular disease9.  Of all of these causes of death in 
Mitchells Plain, five out of the ten would benefit from palliative care: HIV-related illnesses, 
TB, diabetes mellitus, IHD and cerebro-vascular disease.  Considering some of the 
symptoms people with the above listed illness may experience, palliative care aims to 
address the individual’s needs for symptom control, to control their pain, breathlessness, 
anxiety, nausea, constipation and low mood. Palliative care would integrate the person’s 
psychological and spiritual needs into their care.  Most importantly, it would be geared 
towards assisting the individual to live as actively as possible and support their family in 
coping with the challenge of caring for them and managing the process of grieving. These 
are some ways that palliative care would benefit people dying of chronic illnesses, in their 




Call for Improved Palliative Care:  
Globally, the palliative care community has recognised the need for improved palliative care 
in all countries10. In 2002, the Cape Town Declaration stated that palliative care is a human 
right, that appropriate drugs should be made available, that improved education on palliative 
care is necessary and that palliative care should be provided at all levels of health care 10. 
This was followed by the Korea Declaration, in 2005, which called on governments to 
improve policies on palliative care integration and education, as well as policies designed to 
improve access to appropriate drugs and make palliative care available to all citizens11. In 
addition the Venice Declaration (2006), supported a call for more palliative care research12.   
Most recently, in January 2014, the WHO passed a resolution which supports all aspects of 
palliative care13.  This resolution comprehensively covers all principles of palliative care in a 
practical manner.  It requests that all members of the WHO comply with providing broad and 
integrative palliative care, to all people (adults and children) across all diseases, including 
non-communicable diseases and infectious diseases, including HIV and TB.  This is a major 
step forward for all people who need palliative care and are not able to access quality care. It 
is also encouraging for those trying to implement quality palliative care around the world.13 
 
Improved Palliative Care: 
Each country has its own standard of palliative care and level of integration. In 2006, the 
International Observatory on End of Life Care (IOELC) undertook research in many areas of 
the world and mapped the level of palliative care that was available in each country14. More 
recently the World Wide Palliative Care Alliance has updated this research and improved on 
the classification that was originally developed by the IOELC15.   There are four levels 
within the classification, stratifying the levels of integration of current palliative care in 
different countries. Currently South Africa holds a classification of 4a.  Level 1 indicates that 
there are no palliative care services.  Level 4 is the highest, but there are 2 components for 
level 4, namely 4a and 4b.  Level 4a is assigned to countries where Hospice and palliative 
care organisations are in the preliminary stages of integration into mainstream service 
provision.  Level 4b is assigned to countries where Hospice and palliative care organisations 
are advanced in their integration into mainstream service provision15.  This classification 
indicates that South Africa still has improvements to make in the area of palliative care, 
more specifically in the integration of services.  South African palliative care experts agree 
with this classification, as they feel there is a long way to go, before South African palliative 
care can compare with countries like the United Kingdom, Canada and the Netherlands16. In 
South Africa there are pockets of excellence, Non-Profit Organisations, religious-based 
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organizations and charities, where good integration is taking place. However there is very 
little structured palliative care offered in the primary health care setting or in hospitals.16 
Harding and Higginson17 conducted a review, in 2003, that attempted to include all palliative 
care research and programmes in sub-Saharan Africa.  They agree that, while there is some 
palliative care activity in South Africa, there is room for improvement.  They highlighted 
some key points relating to the need for improvement of palliative care services in this 
region.  Some important points include: structural and resource challenges, increasing 
coverage and evaluating services.  They concluded that more work needs to be done in this 
region in order to improve palliative care.17 
In the United Kingdom there is a national end-of-life programme, which is aimed at assisting 
health care professionals to improve the quality of care for all patients at the end of their 
lives and to enable patients to live and die where they choose to. To assist in the 
implementation of this improved care, the National Health Service (NHS) supports the use of 
the Gold Standards Framework (GSF), designed to assist primary health care services to 
improve the care given to the patients facing life-threatening illnesses. The GSF was first 
developed to assist with the care of patients dying from cancer, but has subsequently been 
adapted to assist in the management of patients suffering from any chronic illness which 
threatens their lives. The aim of the GSF is to provide a ‘Gold Standard’ of care for each 
patient who is nearing the end of his/her life and a primary health care registry of all ‘Gold 
Standard’ patients to ensure that they receive coordinated care at the time of greatest need. 
The processes of the GSF assist with the identification of all patients who are nearing the end 
of their lives, assessment of their needs, symptoms, and preferences, and the formulation of 
plans designed to manage their care, accordingly. The goals of the GSF are18: 
1. To improve patients’ symptoms 
2. To enable patients to live and die at their place of choice 
3. To provide security and support to enable better advanced planning and fewer crisis 
admissions to hospital 
4. To empower and support care givers  
5. To improve the confidence of staff administering palliative care 






Current Palliative Care in the Western Cape: 
The Abundant Life Palliative Care Programme19 was started in 2009 at Victoria Hospital in 
Wynberg, based on the GSF. Its aim is two-fold 
1. To assist people living with organ failure and other non-communicable diseases 
(NCDs) to enable them to stay at home and continue to be a part of the household for 
as long as possible 
2. To assist the people caring for terminally ill patients, to do so with confidence and 
competence.  
The programme makes use of an interdisciplinary team, led by a physician and a palliative 
care trained nurse, with a part time social worker involved as well.  The mainstay of the 
programme is individual assessment and optimisation of the person’s medical care, with 
support of the patient and family, by means of a weekly support group. This programme has 
managed to reduce the number and length of hospital admissions, thus saving costs to the 
hospital and the individuals19.  It has also helped more people to die at home, rather than 
away from their families, in hospital.19 
St Luke’s Hospice, a member of the Hospice Palliative Care Association of South Africa 
(HPCA), is active in the city of Cape Town, Western Cape.  This organisation provides care 
at home and in the form of a small in-patient unit, for people suffering from any form of 
cancer, as well as some neurological conditions (e.g., Motor Neuron Disease).  The members 
of the organisation have chosen to limit the extent of their care to certain diseases, as they 
feel that this enables them to continue to provide good care for certain patients, and avoid the 
risk of becoming over-burdened by trying to cover all diseases that require palliative care.  
They assist with providing training for health care workers and lay people, with regard to all 
aspects of palliative care.  They are a Non-Profit, Non-Government Organisation (NGO), 
relying mainly on community donations to fund the service, which is provided free of charge 
to all patients, except those with medical insurance.   
In the Western Cape there are various Home-Based Care organisations, which usually work 
in a small area, or have various branches in different suburbs.  They consist of home carers, 
who visit several homes each week, carrying out various roles, from bed bathing and wound 
dressing, to directly observed treatment (DOTs), in the case of home-bound TB patients.  
Home carers are not nurses and have very basic nursing training.  Ideally, these NGOs 
should have a registered nurse to oversee the carers and to assess clinical needs, such as the 
need for pain management and relief from other distressing symptoms.  The presence of the 
registered nurse is not guaranteed and the nurse, if present, is overstretched and not able to 
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include patient assessment and management, in addition to her responsibilities of supervision 
of carers and management of the service.  
There are a few facilities in Cape Town that can accommodate people needing short-to 
intermediate-term placement, for medical reasons.  Examples of such facilities include 
Living Hope, Life Esidemeni and St Joseph’s Home.  St Joseph’s Home provides care for 
children with palliative care needs. The Intermediate Care Policy of the Western Cape 
Department of Health, provides a platform for the development of intermediate care facilities 
which would provide care for people in need of post-acute care, rehabilitation, restorative 
and palliative care20.  Currently these facilities are often far from where the family may stay 
and do not offer a permanent solution for people who may survive for more than a few 
months, living with their illnesses. 
According to the HPCA, there were 165 sites providing palliative care in South Africa in the 
years 2012 and 201321.  Of these, 25 sites were based in the Western Cape.  These sites 
catered for people living with TB, HIV/AIDS and non-communicable diseases, such as 
cancer, organ failure and dementia21.21 
 
Palliative Care Research in Africa: 
In general, there is less medical research done in Africa compared to other continents22. 
Within Africa, certain countries produce significant medical research and many produce very 
little or none. Volmink suggests that reasons such as political and economic differences may 
be responsible for this discrepancy22. Significantly, South Africa is one of the countries that 
is reported to produce significant medical research22.  In the context of palliative care 
research, there has been a call, made in the Venice declaration, for more palliative care 
research, worldwide12.  
Most palliative care research coming out of Africa, at present, focuses on HIV-related illness 
and some attention is given to cancer related palliative care. Very little attention has been 
given to the non-communicable diseases, such as heart failure or renal failure.  A shift in this 
trend is starting to emerge with the research from Abundant Life and a prevalence study of 
local palliative care needs in Cape Town, South Africa19,23.  
 
Tools for Research: 
Because palliative care is about improving a patient’s symptoms and emotional, spiritual and 
psychological wellbeing, proving that an intervention has been beneficial can only be based 
on a subjective response, from the patients themselves.   It is difficult to use objective 
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markers to verify improved outcomes24. There are no laboratory tests to validate outcomes. It 
is a difficult area in which to verify outcomes because there are many confounders. For 
example, one of the criteria for joining a palliative care programme is that a person is nearing 
the end of his/her life. Some people may get frailer during the study and may not be able to 
complete the study. Some people may not survive to the end of the study. Because palliative 
care relies on subjective markers to verify outcomes, the patient needs to be able and willing 
to contribute to the study, which he/she may not be able to do as the illness progresses or 
he/she passes away. Studies investigating the efficacy of palliative care methods, therefore, 
have high rates of attrition. 
There are various tools available to assist with testing outcomes (e.g., testing symptoms and 
emotional wellbeing of the patient and the primary care giver) in palliative care 
interventions. The African Palliative Care Association African Palliative Outcomes Scale 
(APCA African POS) has been validated for use in Africa25.  It is a short, 10 question tool 
and quick to administer. It was developed in response to a need for quick, effective and 
efficient research in African palliative care facilities26.  With the aid of the APCA African 
POS, one can statistically analyse outcomes of symptoms and emotional wellbeing of 
palliative care patients. If an improvement in outcome can be demonstrated, this may support 
researchers advocating the need for palliative care and the programme it is testing.  
 
Description of Study Population: 
The population, from which the sample for this study was drawn, consisted of the residents 
of Mitchells Plain, a suburb and community within the city of Cape Town, in the Western 
Cape province of South Africa.  Mitchells Plain covers a large area (43,76km2)  and is 
inhabited by a large population (310 484 people)27.   The origins of the suburb date back to 
the implementation of the Group Areas Act, which resulted in the forced removal of 
coloured people from District Six and other areas, to Mitchells Plain.  Prior to 1990, it was 
made up of only coloured people, both Cape Malay and coloured people of mixed ancestry, 
with a mix of Christianity and Islam as the two main religious groups.  This suburb is seen as 
one of the lower socio-economic coloured communities in Cape Town. 
Post 1990 and the abolishment of the Group Areas Act, Mitchells Plain has seen a change in 
the demographics with relation to ethnicity, but that change has been small.  The culture of 
gangs, currently evident in the area, was present even before 1990 and it continues to play 
havoc with the peaceful nature of many of the inhabitants.  This violence explains why the 
leading cause of death in Mitchells Plain is homicide and not a disease related death, as is 
evident in other parts of Cape Town9.  At the last census (2011), the population was 
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estimated to be 310 484 (8.3% of the total population of Cape Town), with 91% falling into 
the ethnic group of coloured27.   
The site for this research study, Mitchells Plain Community Health Centre, was chosen for 
various reasons.  This area has very little in the way of palliative care services.  Those which 
do exist are poorly integrated and, the clinic in which the study was set, is a very busy 
primary health care clinic.  It was felt that this programme could benefit the community at 
large.   
 
Health Care Facilities in Mitchells Plain: 
At the time this study was conducted, Mitchells Plain was serviced by many private General 
Practitioners and one private hospital.  Government health care services consisted of 5 nurse-
managed and nurse-run municipal clinics (open five days a week, from 8:00 am to 4:00 pm).  
There was also one 24-hour clinic, MPCHC, open seven days a week, where the study was 
conducted.  The Mitchells Plain District Hospital (MPDH), which offered limited patient 
care for level-one medical patients and had no out-patient facilities, was the only district-
level hospital in Mitchells Plain.  The other district-level hospital that serviced Mitchells 
Plain was GF Jooste Hospital (GFJ), which was in Manenberg, 10 kilometres away.  GFJ 
received surgical patients from Mitchells Plain.  The tertiary hospital that serviced Mitchells 
Plain was Groote Schuur Hospital (GSH), which received patients for complicated surgery 
and secondary level Medicine.    There was a tertiary Psychiatric hospital in Mitchells Plain, 
Lentegeur Hospital, which serviced the community (and a large part of the Western Cape) 
for specialty psychiatric services. 
Prior to this study, the Western Cape Department of Health had started the building of a new 
district hospital in Mitchells Plain.  The hospital only officially opened in the new building 
after completion of this study.  At the time, MPDH was operational, but was located in two 
empty wards in the psychiatric hospital, Lentegeur Hospital.  As mentioned above, it had 
capacity for a fixed number of in-patient beds, but no out-patient facility.  Carnation Ward, 
one of the MPDH wards at Lentegeur Hospital, had palliative care trained staff.  In 2013, 
after completion of the study, GFJ was closed and all services and staff were moved to 
MPDH in the new building.  This new hospital caters for acutely ill people, including people 
in need of palliative care.  It also makes use of Carnation Ward, still based physically at 
Lentegeur Hospital, but run and staffed by MPDH, as a step-down facility for those patients 
who are more stable but still in need of in-patient care.   
Magnolia Ward used to be part of MPDH prior to the occupation of the new hospital.  Since 
the opening of the new hospital, it has changed in its function and is now run through public-
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private partnership by Life Esidemeni.  It has been identified by the Western Cape 
Department of Health as an intermediate care facility for convalescent, rehabilitation and 
palliative care patients. HPCA is providing palliative care training to equip the ward to 
provide palliative care to patients needing this service. The University of Cape Town 
palliative care teaching staff are concerned that none of the doctors providing part-time 
medical services to Life Esidemeni are trained or experienced in palliative care (E. Gwyther, 
personal communication, 10 April 2014).  So, although this has been labeled a facility 
providing palliative care, the reality is quite different.   
 
Palliative Care in Mitchells Plain: 
Other palliative care services in Mitchells Plain, at the time this study was conducted, 
consisted of community-based Hospice care, provided under the umbrella of the St Luke’s 
Hospice in Kenilworth.  This consisted of community nurses visiting patients, who suffered 
from any type of cancer, in their homes.  These nurses worked together with the other health 
care workers involved in each person’s care, but no formal link existed between St Luke’s 
Hospice and the MPCHC. 
There were two Non-government organisations that work in the community that offered 
home-based care.  This service was provided by home carers, who provided simple nursing 
care and are accessed through the CHC, by referral letter.  There was little interaction 
between the CHC and the NGOs at the time this study was conducted.   
Palliative care is an important aspect of holistic health care.  At the time this study 
commenced palliative care was practised in Mitchells Plain, but there was a lack of 
integration between services and very poor palliative care practised within government 











CHAPTER 2: LITERATURE REVIEW 
Palliative care is a relatively young specialty within medicine.  It became more formally 
recognised by the medical community as a result of the work Dame Cecily Saunders started 
in the United Kingdom, in the 1960s.  Interest in the idea slowly spread to all corners of the 
globe, initially only in first-world countries and, more recently, in many third-world 
countries.  From one country to the next, the model on which the palliative care programmes 
are based varies.  They all focus on the management of pain and other symptoms, with the 
primary aim being to improve the quality of life for people in the last months of their lives.  
Within the field of palliative care, there are still many questions that need to be answered and 
there is still much research to be done.  For example, with certain diseases, it is unclear when 
palliative care should be initiated and which model is best suited to the particular setting.28 
The search for this literature review was conducted using Medline, Pubmed and Africa-wide 
databases. The words “palliative care” and “chronic diseases” were initially used.  
Thereafter, “APCA African POS” was searched for, to find research that made use of the 
tool that was used in this study.  Lastly, local, South African published research was found 
by word of mouth.   
 
Overview of the Research Available: 
In 2004, a group of palliative care experts in the United Kingdom gathered to create 
evidence based guidelines for the care of people dying from cancer29.  As a result of this 
work, Higginson wrote an editorial outlining what types of research they found in palliative 
care to aid them in the formulation of the guidelines and to highlight where the biggest gaps 
in palliative care research were.  She notes that palliative care research is quite different from 
other areas of research in medicine.  For example, when evaluating services, the methods 
used need to be different from other research, like drug trials, as randomisation and 
controlling the dose or care administered is very hard.  And outcomes of a service are more 
difficult to assess, when dealing with a frail population, which is the case in palliative care.  
The wealth of knowledge in palliative care comes from studies looking at the needs of the 
palliative care population, the importance of good palliative care and options for solutions to 
providing palliative care29.  There is very little evidence on finding the most effective 
solution to providing palliative care and suggests ways to address this.29   
With this overview in mind, in this literature review I aim to present a selection of the 
findings yielded by palliative care research conducted to date.  I will focus on chronic 
illnesses, family carers and different programmes available within palliative care.  I will 
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compare international research to research conducted in Africa and, more specifically, in 
South Africa.  
 
Research Focusing on Elderly People:  
When trying to look at the needs of a palliative care population, it could be deemed unethical 
to ask hard or difficult questions of a person who is dying.  They have so much to handle and 
asking them questions that may upset them could be seen as unethical.  There are several 
studies in which such questions are asked of older people30–33, because, although, they are 
may be near the end of their natural life, they are not necessarily ill with a life-threatening 
disease.  Researchers assume that elderly, relatively healthy people are less likely to be upset 
by sensitive questions relating to ill health and death, but may have started to think about 
how they hope that their death will be handled, when the time comes30.  If these studies were 
conducted with younger people, who were not ill, it may be very difficult to get helpful 
answers, because the participants may never have thought about the issues of death and 
dying, nor their preferences for how the end of the lives should be handled by the people 
around them. 
Clark et al.30 performed a study where they invited older people, over the age of 60 years, to 
attend a focus group, where they were invited to share their stories or experiences of death.  
The themes which emerged from the sessions conducted with such focus groups included the 
following: having a desire to die with dignity, being involved in the decision-making 
processes associated with the end of their lives, not dying alone and not being in pain when 
they die.  These are some of the core principles of palliative care and, while they might make 
logical sense and be taken as a given by those involved in palliative care3, these themes need 
to be validated by asking people who are facing the end of their life.30   
Arber et al.31 investigated preferences of older people with respect to how the end of their 
lives should be managed, by gender.  In this study they approached older people in the 
United Kingdom who were not necessarily ill, but over 60 years old, and asked them 
questions relating to decisions that may affect them as they face death, if they were to be too 
ill to make the decisions themselves.  This study found major gender-related differences in 
how the individuals anticipated they would want decisions to be handled in the end stages of 
their lives. Older women seemed more concerned with being a burden and not wanting life 
prolonging therapies, while men expressed the desire for the administration of life 
prolonging therapies and were less concerned about being a burden to anyone around them.31  
Pierson34 asked people who had Acquired Immunodeficiency Syndrome (AIDS) to comment 
on what aspects of their death they thought would make it a ‘good death’.  This study 
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confirmed that people who are facing the end of their lives worry about dying in pain, dying 
alone and having drawn out deaths.  A theme from this study showed a split between people 
wanting to die with loved ones at home and others wanting to die in hospital, so as not to 
burden their families.  Those who were spiritual had desires for certain rituals or ceremonies 
relating of their spiritual lives to be completed near their death, e.g. having their last rights 
performed.34  
Gott et al.32 performed a similar study with similar outcomes, validating that people want to 
die with loved ones around them and do not want to be a burden to their family32.  In 
Singapore, a study was performed to assess what Singaporeans wanted at the end of their 
life33.  Singapore has a strong Asian influence with Asian culture.  Their study implied that 
older people, in Singapore, rely on their families to make decisions for them as they get 
older33. 
In 2014, Downing et al.35 conducted a study in Kenya, investigating the preferences and 
priorities people had towards death and dying.  They conducted a street survey of Kenyans in 
Nairobi, asking people over the age of eighteen a selection of questions on death and dying.  
Although the mean age for this sample population was 27 years, 42% reported having cared 
for a family member or close friend in the last months of that person’s life, indicating that 
these issues are not only pertinent for the elderly in Africa.  Downing et al. found that, to the 
respondents, having a positive attitude and ensuring that family members were not concerned 
about them when they are dying was more important than relieving symptoms.  Only half of 
the respondents wanted to die at home and 23% wanted to die in hospital, which indicates 
that the palliative care principle of choosing where to die is more relevant than necessarily 
dying at home, as some individuals would advocate.  This study is a good start to looking at 
people in Africa’s preferences for good palliative care.  Unfortunately this study was not 
randomised nor generalised, in terms of geographical location and sampling, given that it 
was conducted in select parts of Nairobi, in areas of Nairobi that were deemed safer for 
researchers, at particular times of the day.  It thus has a bias for unemployed urban people.  
People at work, with a potentially higher level of education and information on medical 
treatment and care, were excluded by virtue of the methodology.  And people living in rural 
areas were not included.  So, although this gives a good introduction to Kenyan residents’ 
perception of death and dying, it is certainly not a comprehensive summary and needs 
broader inclusion criteria.35     
The studies considered in this section of the literature review highlight the importance of the 
themes of pain, dying alone, having drawn out deaths and decision making around the time 
of dying, to those who are facing death. 
14 
 
Patients and Family: 
There is a significant body of research that has been conducted on patients, themselves.  
Some studies have aimed to assess the symptom burden that palliative care patients 
encounter, some have aimed to assess the needs of the patients or the success of a palliative 
care intervention.  Palliative care acknowledges that the care of a person who is dying is best 
done in the context of their family, including the family and the primary caregiver in 
programmes for palliative care3,36.  There are studies that have been conducted on the 
families and caregivers of patients in an attempt to improve the understanding of what 
aspects of care best help the family in coping with the death of a loved one.  
 One area of palliative care that has been well researched and continues to be researched is 
the dying trajectory37,38.  The dying trajectory is a pattern of decline in health that occurs in a 
specific disease (e.g. pancreatic cancer or heart failure).  Recognising what disease stage an 
individual has reached enables health care workers to predict when a person may die and, 
therefore, the ideal time is for a person to be referred to a palliative care programme.  
Idealists would say that a person qualifies for palliative care as soon as they have been 
diagnosed with a life-threatening illness.  However, most palliative care programmes cater 
for people who are dying and not people who are still able to go to work and lead a fairly 
functional life.  Thus, the need to identify when a person needs to be referred to palliative 
care is an important aspect in the initiation of palliative care.  Much research has been done 
in patients with cancer, but there are still questions about other chronic diseases, which 
become a way of life for many people.  For example, it is difficult to know when to initiate 
palliative care in the case of a patient diagnosed with heart failure and COPD.   It is 
generally difficult to know what treatment modalities to implement in the palliative care of 
chronic diseases.  Most guidelines for chronic diseases give advice on how to prevent 
progression and what medication prevents morbidity and/or mortality, not what medication 
or treatment improves quality of life in a person who is facing the end of their life.  
In 2011 Kheirbek et al. conducted a study of the dying trajectory of heart failure patients37.  
A previous study (conducted in 2007) had determined that it is very difficult to predict the 
dying trajectory for heart failure38.  However, Kheirbek et al. discovered that, although it is 
not easy to determine the dying trajectory of heart failure, there are some indicators which 
allow a reasonable analysis to be conducted37.  Kheirbek et al. found that twenty percent of 
deaths attributed to heart failure are unexpected deaths37.  In the other 80% of such cases, the 
patients show a gradual decline in functioning over their last six to twelve months of their 
lives.  The authors recommend that clinicians should consider two key points in caring for 
heart failure patients.  Firstly, when considering the dying trajectory, they should take into 
account other comorbidities which often co-exist with heart failure.  Secondly, mortality is 
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more dependent on the change in prognosis with time, as opposed to with the value of an 
index.37 
An in-depth, qualitative study of COPD patients39 reported that the healthcare workers found 
it difficult to know when to initiate palliative care for people living with COPD, as the 
disease is slowly progressive and there is no clear point when palliative care should be 
started.39  There are guidelines about when to initiate palliative care in heart failure and 
COPD but clear research to support this is not evident40.   
Some studies combine the patient’s and the family’s perceptions of the service they have 
received41.  In a study of people who had suffered an acute stroke, the patient’s wishes, as 
well as the family’s perceptions, were explored.  All parties wanted better communication 
with their doctors.  Families wanted to know the prognosis, although some patients did not 
want to know.  Many of the family members did not associate death with a stroke and so 
having that discussion was deemed helpful and they did not regret being told that the patient 
was nearing the end of their life.41  These findings confirm the need for timeous palliative 
care. 
In palliative care, qualitative research helps to broaden our understanding of dying.  Pinnock 
et al.39 conducted in-depth interviews with people with severe COPD and attempted to 
understand the complex nature of the disease.  This study highlighted the fact that there is no 
clear point when people with COPD become palliative and people with COPD see their 
symptoms as a way of life, not a sign that their life is near the end.  This study highlights the 
need to ensure good symptom control and emotional support throughout the illness with an 
increase in the palliative care component as the disease progresses. There is difficulty in 
deciding when to start treating a person suffering from COPD as palliative, as mentioned 
above39.  Unlike cancer, when there clearly comes a point when it is appropriate to withdraw 
anti-cancer treatment, optimal treatment of COPD should be continued in conjunction with 
palliative measures.39 
When dealing with people, individual personalities of patients and families surely play a part 
in how they cope with this life event, that of dying.  Gilbar et al.42 investigated the coping 
styles of people with end stage renal disease, in a study conducted in Israel. They found that 
different people have different coping styles; some cope with stress better than others.  And 
these coping styles play a big part in coping with a terminal disease.  Understanding one’s 
own patient’s coping style can help in caring for them, as a healthcare worker.  Different 




Given that personalities play a role in coping with facing the death of a family member, or of 
oneself, one must surely consider to what extent the disease itself may play a role in how a 
person copes.  Steinhauser et al.43 investigated patients with cancer, heart failure and a 
debilitating stroke.  They found that the disease itself does not have an influence on 
functional status, but it is rather the severity of the illness, that determines the life 
experience, along with emotional and social factors.  Patient outcomes, depression and 
anxiety were most strongly associated with socio-demographic details like gender, education 
and perceived financial security.  They conclude that non-biomedical factors affect the 
overall experience of life-threatening illnesses.43   
Garlo et al.44and Burton et al.36 support the findings of Steinhauser et al.43 Burton found little 
difference on the burden of carers across different diseases, but found that the burden on 
carers was more related to coping styles and the amount of support they had.  They conclude 
by recommending that programmes provide support to the carers and consider their 
psychosocial support in the overall service of providing palliative care.36 
The title “Advanced Care Directive” (ACD) is used to refer to the consideration given to 
planning for the future, within the context of palliative care.  This is where the patient and 
family, together with their doctors, talk through issues that may arise close to their death and 
consider what everyone’s wishes are.  Thus, when the time comes, the issues have already 
been discussed and the patients’ desires can be taken into account. Two studies present the 
discussions that the researchers had with older people, talking about ACDs45,46.  Both 
studies’ results show mixed responses, as some people want their wishes carried out and 
others seem to want their families to make decisions for them when the time comes.45,46  
Two South African studies investigated professionals involved with palliative care’s 
perceptions on ACDs, advanced directives or living wills47,48.  Stanford et al.47 started her 
focus groups by introducing the concept of an ACD and asking about perceptions of an 
ACD.  Their results show that professionals do think it is a good concept, but there was some 
reluctance to initiate this discussion within ones’ own family as result of the stigma 
associated with death and dying in some cultures.  The participants felt that a discussion 
around an ACD should be held prior to a health crisis.  Within the methodology, there was a 
range of professionals invited to the focus groups and the reason each group was invited was 
not made clear.  Inviting hospice staff and spiritual care providers is understandable.  
However, including primary school teachers, who are not routinely involved with palliative 
care, was a perplexing choice.  Had they been trying to investigate a range of professional 
people’s opinion, then I would have expected a wider range of professionals to have been 
included.47      
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Bull et al.48 restricted their study to healthcare workers involved in caring for elderly people, 
in a small rural town, in South Africa48.  All participants knew of the concept of an advanced 
directive or living will, but most felt that it was not their place to suggest that a patient 
should formulate one.  Rather, they felt their role was to be the custodian of the advanced 
directive or living will.  The author suggests that healthcare workers should meet their 
patients halfway, by introducing the topic and being available to talk about an ACD, not 
waiting for the patient to raise the topic.  This study only included healthcare workers who 
are involved with caring for the elderly, so there is a bias, as they are likely to have come 
across this concept in their work.  This study was also conducted in a small rural area, 
comprising, mostly, of retired middle to upper class white people.  This is not a true 
reflection of South Africa’s population and cannot be generalised to most parts of the 
country.48  
 A study, from the United States, looked at the effect of using ACDs on the patients and 
caregiver stress levels.  It showed that it does reduce the stress but not completely 49.  There 
is a substantial amount of stress evident around the time a person dies and, knowing what the 
person dying would prefer, does not necessarily make choices easier.  
 
Identifying People in need of Palliative Care: 
Clinicians find it difficult to anticipate when a person may die from a chronic illness and 
Glare50 states that when clinicians use, what he calls, temporal predictions, i.e. their personal 
judgment, they are overoptimistic.  Glare suggests using probabilistic predictions, using 
concrete signs and symptoms, along with laboratory results, to determine a person’s 
prognosis50.  One such model is the prognosis in palliative care study predictor model, which 
is complex and time consuming51.  The Gold Standards Framework: Prognostic indictor 
Guide formulated in conjunction with a number a palliative care experts and using many 
different prognostic models, is used throughout the United Kingdom and is the prognostic 
indicator guide that has been chosen for this research project40.     
The Gold Standards Framework: Prognostic Indicator Guide40 suggests three triggers to 
palliative care.  These are the surprise question: ‘Would you be surprised if this patient were 
to die in the next 12 months?’; patient choice or need; and clinical indicators for palliative 
care such as significant weight loss, physical decline and reduced physical activity, recurrent 





Palliative Care Programmes: 
There are a variety of palliative care programmes around the world; most involve in-hospital 
programmes and out-patient programmes to varying degrees.  Some programmes are 
predominantly in-patient and others are predominantly out-patient, home-based palliative 
care.   
Francke and Kerkstra52 expand on the different types of palliative care services that are 
available in The Netherlands52.  Many countries have similar services, with some being well- 
integrated, as in The Netherlands, and others still striving for that integration.   Francke and 
Kerkstra’s study aimed to describe the services available in The Netherlands and to ascertain 
to what extend there is integration of the services within the national health care system.  
They found services that specialise in palliative care and other services that are relevant to 
palliative care but not specialists in palliative care.  The specialised palliative care services 
included hospices, palliative care units in homes for the elderly, palliative care units in 
nursing homes, palliative care units in a general hospital, a palliative care unit within a 
specialist oncology unit and a children’s home that specialises in care for children in need of 
palliative care.  The other services involved in palliative care included: professional home-
based carers, volunteer carers for patients staying at home, almost-home-houses, nursing 
homes that take an interest in palliative care patients (but have no specialised unit), hospitals 
with no specialised palliative care unit, but with an interest in palliative care, services for 
pain alleviation and services for psychological support.  52 
With regard to the integration of palliative care services in parts of The Netherlands, Francke 
and Kerkstra propose that the integration is satisfactory.  One major reason for this is that the 
Dutch government discouraged private initiatives within the health sector, allowing for good 
integration of the palliative care services, as they are mostly interconnected in the National 
Health Service.  This has resulted in better integration than would be typical of a more 
fragmented health care system, which may develop if more private initiatives were 
encouraged.52  The idea that private initiatives cause fragmented care is valid.  However, in 
Africa and most low income countries, it is almost impossible for the government in each 
country to fully cater for peoples’ every need.  Most low income countries rely on 
international aid or non-government organisations to assist in providing health and social 
care for their people.  Thus it is not a viable solution to place all palliative care programmes 
within the government health care system in South Africa.  But this article does give a good 
overview of the different types of palliative care that can be offered.  African palliative care 
services are usually home care programmes using community care workers as the primary 
carer with professional staff providing supervision and support of care workers. 
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The article described above shows the range of palliative care programmes that exist.  Do 
palliative care programmes make a difference?  Some research shows the impact of actual 
programmes for palliative care: 
Temel et al.53 enrolled people with cancer, suffering from metastatic non-small cell lung 
cancer, into a palliative care study and compared the outcomes with people not enrolled in 
the palliative care programme.  The outcomes showed that patients who were integrated 
early into a palliative care programme had a two-month prolonged survival and clinically 
improved quality of life and mood, compared to the patients not in the programme. 53  This 
supports the need for palliative care programmes.  This study also showed the cost saving 
when a palliative care programme is in place.  The programme results in less hospital 
admissions, shorter stays in hospital and less investigations while in hospital.53  However, 
this study was with conducted with a very narrow subset of participants and cannot 
necessarily be generalised to all areas of palliative care.   
Hanratty et al.54 studied people who were diagnosed with either cancer, heart failure or a 
stroke and were transferred between two or more facilities of care in the previous three 
months.  This study took place in Northern England.  The researchers showed that the 
support across different settings is lacking and the system is too rigid for people who are 
dying – there needs to be flexibility.  The patients felt that communication was not 
satisfactory and they were not being heard.  Their dignity was not upheld.  The researchers 
concluded that transitions of care, near the end of a person’s life, bring much upheaval and 
discomfort for those concerned, and should be avoided as much as possible.54 This kind of 
research can aid in guiding carers implementing palliative care programmes in their work 
and direct their focus when managing a patient and their family. 
It is valuable to have palliative care programmes, but the benefit of these programmes needs 
to be supported by economic evidence that shows it is cost effective to support programmes 
such as this.  In Johannesburg, South Africa, Hongoro et al.55 analysed the cost of running a 
palliative care programme based at a hospital, with outreach into the community.  This is a 
sound basis for most palliative care programmes in Africa.  They found that it was more cost 
effective to run an outpatient programme than only an inpatient programme.  Their biggest 
expense was personnel and they concluded that, if they did not have teaching, advocacy and 
policy making responsibilities, they could cut costs even more.55  This supports an outpatient 
programme in Africa.  A limitation of this study is that all patients involved in the 
programme were HIV-positive.  The study did not give broad consideration to a range of 





Two studies, conducted by Elliot et al.56 and Cobb et al.57 investigated the impact spirituality 
has in palliative care.  Elliot et al.56 performed their study in the United States among people 
with end-stage renal disease.  Their study highlighted the issue of spiritual pain.  It seems 
that, although it was not explicitly stated, most of their cohort were Christian56.  Cobb et al.57 
performed a systematic review of research on spiritual issues within the context of palliative 
care.  The data set was difficult to assess, but it shows the breadth of research on spiritual 
issues, mostly coming out of the United States and the United Kingdom, mostly among 
Christian and Jewish people57.  These studies highlight the need to include spiritual issues in 
a good palliative care programme.   
 
Family Caregivers: 
Several studies have considered family caregivers of people in need of palliative care.  Grant 
et al.58 conducted a systematic review, looking at research on family carers of COPD 
patients.  They found that 40 –70 % of family carers of COPD patients have clinically 
significant symptoms of depression.  Isolation and lack of support result in a higher burden 
on the family carer.58 
Wright et al.59 performed a study to look at the effect of end-of-life care and discussions on 
family caregiver bereavement.  They found that end-of-life discussions are associated with 
less aggressive medical care and earlier palliative care referrals.  Aggressive end-of-life care 
is associated with worse patient quality of life and family carer bereavement adjustment 
afterwards.59 
Harding et al.60 performed a literature review of research addressing programmes for carers.  
They found programmes that included respite care, social networks and activities, one to one 
interventions and group work, all of which attempted to alleviate the stress and burden that 
carers face.60 
Streid et al.61 conducted a study in Uganda and South Africa, investigating the stressors 
experienced by, and recourses available to, caregivers.  Their study included 37 participants, 
of which 31 were female and most were relatives of the patient.  They found that some of the 
biggest stressors were around feelings of isolation and lack of support from the extended 
family, as Grant et al.58 had found.  Stried et al.61 also found that carers were physically 
exhausted and found it agonising watching their family member suffer, because they felt 
helpless and frustrated.  The carer is often the confidant of the patient, and this can be a 
burdensome responsibility.  There were financial stressors, as the patient was often the 
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breadwinner, there were often children of the patient, that needed to be cared for, and this 
care fell to the patient’s carer as well.  This study went on to look at resources the carer used 
to cope with this burdensome task.  They seemed to rely on internal resources, such as 
spiritual beliefs and confidence.  Externally, they relied on family and friends for support; 
many found the patient-carer relationship rewarding and a source of strength.  The stressors 
and resources that carers use to cope with their role are complicated and interwoven.  
Programmes aimed at assisting carers in these stressful aspects of their role and empowering 
their use of internal and external resources would be beneficial to carers.61   
There are a wide variety of ways to support family carers.  And these studies highlight the 
need to provide family carer support within a palliative care programme and into the 
bereavement stage.  Palliative care is not only about the person who is dying, but about the 
family and community as well. 
 
In Africa: 
In Africa, the level of palliative care, the government support of palliative care and the 
amount of research on palliative care varies greatly between different countries and in some 
countries these elements are non-existent14.  Palliative care in South Africa is a recent 
development; the first hospice was founded in the early 1980’s16.  Since then, the HIV 
epidemic has grown exponentially and the need for palliative care has become vitally 
important26. 
HPCA reports that, from April 2012 to March 2013, they cared for 82, 681 patients who 
were dying21.  Of those patients, 59% had a diagnosis of HIV, 33% were diagnosed with 
chronic diseases and 8% had a diagnosis of cancer21.  This shows the range of people in our 
country currently being cared for by a non-governmental organisation aimed at providing 
palliative care.  
In Africa, there is a range of published research, some looking at palliative care 
programmes62,63, the patient outcomes of improved programmes64, the cost effectiveness of 
palliative care programmes55,65 and the barriers to producing palliative care research66–69.  
Ddungu70 discusses the obstacles which inhibit palliative care in Africa and offers possible 
solutions to providing good palliative care in Africa.  Much of what is known about 
palliative care comes from research in developed countries and it is difficult simply to apply 
a framework that is successful in a developed country to Africa.  Firstly, the level of 
healthcare is vastly different and availability of medication is not reliably consistent in 
Africa.  The most important difference, in patient-centred medicine, is that the culture of the 
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people of Africa is different and we need palliative care that is culturally acceptable and 
sensitive.  One of Ddungu’s suggestions is the implementation of appropriate services.  He 
finds the idea of care in the home, by home-based carers (HBCs) highly appropriate for 
Africa70.  It is not feasible to have inpatient care centres and it is more economical to make 
use of HBCs.  It is also culturally acceptable, in Africa, for a patient to be cared for by 
his/her own family, in the comfort of the patient’s own home. 70 
Home-based carers are found all over the world, none more so than in Africa17.  Some are 
from formal community home-based care organisations and have formal training, while 
others are informal carers, who have had little to no training.  Even within the organisations 
where carers have had training, ongoing support and training is needed.  Defilippi and 
Cameron64 published a research project that undertook to give ongoing training and support 
to home- based carers, from a professional nurse, trained in palliative care.  Difilippi and 
Cameron describe the intervention in a clear and simple manner.  Using the APCA African 
POS, the authors showed that support of the home-based carers improved the patient 
outcomes (patient perceptions).  All components of the outcome scale improved with each 
visit.  This study supports community palliative care, but underlines the need for ongoing 
training and support of the community home-based carers, by a trained professional.64 
In Malawi, Francis et al.71 looked at the treatment of Kaposi’s Sarcoma (KS) and the 
efficacy of different treatment options.  The research team also applied the APCA African 
POS to their cohort of patients, in order to assess the feasibility of using the outcome scale in 
HIV-positive people suffering from KS.  It is not clear what their palliative care programme 
entailed, so the change in patient outcomes is difficult to evaluate.  The results of the APCA 
African POS show that symptoms did improve, but the feeling of their life being worthwhile 
and feelings of peace did not improve.  As the details of the programme are not indicated, it 
is not clear if these aspects were addressed in the programme or not.  It is not clear whether 
this is indicative of a problem with the tool, with the programme or with the population 
being studied.  The population is that of a young African population, mostly unemployed and 
facing the end of their life.  This research seemed to focus on the treatment of the KS, and 
the outcomes of that, more than the overall palliative care outcomes, as the title of the article 
may suggest.  The authors state that they experienced difficulty with the  use of the APCA 
African POS, because the participants found the numerical rating difficult to use, which 
would point to a problem with the tool.71 
Selman et al.72 investigated the APCA African POS in more detail, in South Africa and 
Uganda, with regard to being able to pick up spiritual concerns.  They hypothesised that the 
questions on feeling at peace and feeling that life was worthwhile are related to each other 
and give an indication of spiritual wellbeing.  They used the two questions from the APCA 
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African POS in conjunction with the Spirit 8 tool, which has only been validated for use in 
Uganda.  They found that these two questions do relate to spiritual wellbeing and although 
they do not get to the heart of the matter for the patient, they do give an indication of 
potential unresolved concerns.  This study highlighted that the question on feeling at peace 
was interpreted, by their participants, as being prepared for death, having forgiven people, 
accepted their own mortality, and on a more practical level, socioeconomic stability and 
symptom control.  Some participants interpreted feeling that life was worthwhile as more of 
an attitude of hope and gratitude, while others interpreted it as being able to work and 
contribute to the family, being of value to people around them and being helpful or useful. 72  
This study validates the use of certain questions in the APCA African POS to indicate 
spiritual wellbeing in participants.  
In Johannesburg, South Africa, there is a palliative care project that is based at Chris Hani 
Baragwaneth Hospital in Soweto55.  This project started in 2003 and is a hospital-based 
programme with an inpatient consultation component, a large outpatient service including 
home visits and a drop-in centre, as well as a training and advocacy aspect.55 
Hongoro conducted a cost analysis of their programme55.  He showed that their programme 
is more cost effective than an inpatient programme.  The programme saw each patient, on 
average, twice in hospital and nine times at home.  The biggest cost saving relates to HIV 
patients in need of palliative care who are not yet on treatment for their HIV, as they tend to 
have a longer stay in hospital per admission and this can be reduced by being seen at home.  
This study supports the need to have an outpatient based palliative care programme.  The 
limitation with this study is that all patients had either HIV or cancer.  In keeping with many 
palliative care programmes in South Africa, no patients with other life-threatening chronic 
diseases were cared for.55 
In this study, the APCA African POS was used to determine the effect of their palliative care 
service and researchers found that there were significant changes in the patient outcomes 
relating to family worry, symptoms and pain, all improving by more than 50%.  While all 
other areas improved, they were not as significant.55 
The authors admit to some limitations in their cost analysis.  An interesting concern was 
raised by the authors with regard to the people that they serve.  They noted that, with 
increasing poverty, many people live in cramped environments, sharing a bed, and the home 
may have more than one person who is ill, making it very difficult to care for someone who 
is dying.  So, their conclusion is that, although palliative care supports the idea of people 
dying at home, with their family, it might not be practical for all palliative care patients. 55 
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DesRosiers et al.19 describes a palliative care programme in a government hospital in Cape 
Town, in South Africa.  This programme has the objectives of providing good palliative care, 
reducing hospital admissions and assisting people to die at home rather than far from their 
loved ones.  They showed that their programme can meet these objectives.  Their cost 
analysis was very simple, looking only at days admitted, not taking into account personnel, 
investigations or medication that might differ between a control group and the intervention 
group.  However, with the limitations in mind, they were able to demonstrate a reduction in 
number of days in hospital and number of admissions in the intervention group.19 
A study conducted in Cape Town, South Africa, in 2012 investigated the prevalence of 
patients in hospital, who would qualify for palliative care23.  Van Niekerk and Raubenheimer 
studied admissions to adult acute care beds in all hospitals in Cape Town, in a three-month 
period.  Depending on its size, each hospital was sampled over a period of one to two days.  
They used the GSF Prognostic Indicator Guide as an indicator of qualifying for palliative 
care.  The study included 11 hospitals, with 1443 patients reviewed.  The average age for 
patients sampled was 48 years.  The overall prevalence of palliative care in this study was 
16.6%, with a range between hospitals of 7.1% to 28.7%.  Within medical wards, the 
prevalence was found to be 20.3%.  This implies that one fifth of medically ill patients, 
admitted to hospital, are in need of palliative care.  One limitation of their methodology is 
that they conducted their data collection from November to February.  Many people live and 
work in Cape Town, but travel home to rural parts of the country, from where they originally 
came, for Christmas.  They travel home from mid-December and return from mid-January to 
March.  It is possible that a person who knows they are dying may choose not to return to 
Cape Town in the New Year and rather stay in their family home, far from Cape Town.  This 
indicates that the true prevalence of palliative care may in fact be higher than this study 
suggests.   Van Niekerk and Raubenheimer conclude that there is potential for improved care 
of patients, a potential to reduce costs and improve communication between facilities with 
palliative care programmes in place.  They recommend palliative care programmes in 
primary health care.23 
The first three studies discussed above show a range of interventions and approaches to 
palliative care research.  However, all studies were conducted on patients with HIV or cancer 
(with the acknowledgment that one study was specifically on patients with an HIV related 
disease).  No mention is made of any patients being cared for with chronic diseases.  The last 





RATIONALE FOR RESEARCH 
Much research is being done in the developed world on chronic diseases. However, in 
Africa, most palliative care research is carried out on patients with HIV and there is limited 
research on patients with cancer.  In South Africa, chronic diseases are the leading cause of 
death in people over the age of 65 years, but there is a lack of research into the care of these 
people at the end of their lives.  The programme described by DesRosiers et al.19 is a good 
example of what can be achieved in our setting.  Van Niekerk and Raubenheimer show the 
extent of the need for palliative care across the disease spectrum23.  Higginson advocates for 
more research evaluating palliative care services29.  We need specific research to evaluate 
patient outcomes in patients involved in a Government healthcare facility-based palliative 
care programme, and we need to give consideration to patients facing a broad spectrum life-
threatening illnesses.  
In South Africa there is poor integration of palliative care services with the government-
provided healthcare sector, which most of the population accesses.  It is possible to integrate 
palliative care services and we need researchers to evaluate how to implement this service in 
the primary health care setting. We need to find good palliative care that is simple to 
administer and has been shown to improve patient outcomes. This research has evaluated a 
palliative care programme in the primary health care setting, in an attempt to determine its 
















AIMS AND OBJECTIVES 
Aim:  
To evaluate the patient reported outcomes at a Community Health Centre prior to an 
intervention and to evaluate the impact of an intervention involving a support group and 
focused care for people facing life threatening illness.  
 
Objectives:  
 Determine the prevalence of people with palliative care needs at Mitchells Plain 
Community Health Centre.  
 Assess the physical, psychological and spiritual concerns of people facing life-
threatening illnesses, prior to an intervention.  
 Assess the extent to which people with life-threatening illnesses get admitted to 
hospital or seek urgent medical attention, prior to an intervention.  
 Determine whether or not there is a change in patient reported outcomes experienced 
by people facing life-threatening illness when an Abundant Life programme is 
implemented in the Community Health Centre.  
 Determine whether or not there is a change in the number of admissions to hospital 
or frequency with which patients seek urgent medical attention when an Abundant 
Life programme is implemented at the Community Health Centre.  
 Conduct an audit of care according to the patient reported outcomes.  
 Evaluate the effect of the Abundant Life programme on the participants in the 











CHAPTER 3: METHODS 
Overview: 
This study was conducted in a primary health care clinic, over a period of six months.  A 
research assistant was employed to run the programme and collect the data.  Patients were 
referred from the clinic and recruited to the programme by the researcher.  Initially, eligible 
participants were recruited to Group A.  The research assistant applied the APCA African 
POS tool to them, weekly, for six weeks.  After recruitment to Group A was complete, 
recruitment to Group B commenced.  At this point in time a support group was started for all 
the participants who had been recruited.  Each participant was invited to attend a doctor’s 
consultation.  Thereafter the patients and their families were invited to attend the support 
group sessions.  After six months, the entire programme was terminated.  Figure 1 shows the 









Figure 1: Schematic representation of study programme timeline 
Study Design and Setting:  
This study used a prospective cohort design.  Data collection was conducted at Mitchells 
Plain Community Health Centre (MPCHC), based in the Mitchells Plain/Klipfontein 
Substructure of the Western Cape Metro District Health Services (MDHS), Cape Town, 
South Africa.  
 
Study Population:  
The study population consisted of patients attending MPCHC for medical management.  
Using an adaptation of  the Gold Standards Framework: Prognostic Indicator Guide40 
(Appendix A), clinicians identified patients  who qualified for palliative care and invited 
them to join the study.  
(Abundant Life Programme) Research Timeline 
May  
2012 
July  September November 
2012 
June August October 
Recruitment to Group A 
Recruitment to Group B 
Support Group Sessions 
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Selection Criteria:  
All patients were over the age of 18 years and met the criteria for palliative care based on the 
Gold Standards Framework: Prognostic Indicator Guide40. A family member of each patient 
was invited to be included in the study, provided the patient gave consent for their inclusion. 
The family member was also over the age of 18 years.  If there was no family member to 
join the study, or if the patient or family member did not consent, the patient was not 
excluded from the study.  Mental competence of the patient was not formally tested.  Any 
participant who had the diagnosis of dementia, was not included in the selection for Group A 
or B (see below for a description of Group A and Group B), as their neurological diagnosis 
may have compromised the accuracy and validity of their responses.  If a participant was 
found to be confused during the informed consent process, they were not invited to join 
Group A or Group B.  Participants, who were excluded from Group A or Group B, on the 
basis of mental competence, were still included in the collection of demographic information 
and in the intervention by, being invited to attend a consultation with a doctor and then being 
invited to join the support group.  Allocation to Group A or Group B is explained in the 
section on Sampling.  Only people speaking English, Afrikaans or isi-Xhosa were included 
in the study.  Some patients were referred to the study, but contact was lost prior to them 
giving consent to join the study.  Regaining contact with them was attempted twice, before it 




All patients identified as being palliative care patients, during the study, were asked to join 
the study and provide information.  Of that cohort of patients, the sampling for two groups 
was convenience sampling.  The first patients, who consented to the research, were asked to 
join Group A, until more than 16 participants had been recruited.  From the commencement 
of the recruitment of Group B, all participants, who were eligible to join Group B, were 
invited to join Group B, until the conclusion of the programme. 
Sample Size and Duration: 
The estimation of sample size was calculated based on a two-sample means test.  The 
requisite sample size for the test was calculated assuming β = 0.1 and α = 0.05 (SD = 1, two 
tail).  This test indicated that the minimum number of patients required to perform an 
analysis with these power- and significance parameters was 32, 16 in each group.  
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We recruited 20 participants to Group A and 21 participants in Group B.  The reason for 
recruiting more than 16 patients to group A, was convenience and to allow for loss to the 
study.  We continued recruiting patients until the end of the week in which we had recruited 
the 16th participant to Group A.  When recruiting patient to Group B, we continued recruiting 
patients until the completion of the programme, as we suspected that there would be attrition 
and we may need more patients at the outset, to compensate for this attrition and allow 
reliable statistical analysis in spite of it.    
From an initial survey of the patients attending the MP CHC, it was estimated that a time 
period of six months would be sufficient time for completion the study.  
 
Data Collection Tools:  
Demographic Data:  
The researcher developed the Demographic Data Collection Sheet (Appendix B) in 
collaboration with the clinicians of MPCHC, to ensure that all relevant personal data were 
collected. The Demographic Data Collection Sheet was used to collect information about 
recent admissions to hospital or visits to the MPCHC Trauma Unit.  These data were used in 
the analysis of the APCA African POS data and comparison of patient outcomes.  For those 
patients who were not invited to join Group A or Group B, or who, after giving consent for 
the overall programme, did not wish to be more involved in either Group A or Group B, this 
information will be used to provide more insight into the demographics of the population in 
need of palliative care in MPCHC.   
 
Research Tools:  
African Palliative Care Association African Palliative Outcome Scale (APCA African 
POS)  
The Palliative Outcome Scale was developed by the Department of Palliative Care and 
Policy, at the King’s College School of Medicine and Dentistry, and Saint Christopher’s 
Hospice, New Medical School, Bessemer Road, London24.  The Palliative Outcome Scale 
was adapted for use in Africa by the African Palliative Care Association (APCA) in 200773 
(Appendix C).  It has been validated for use in South Africa, in English, Afrikaans, Isi-
Xhosa, Zulu and seSetho25.  This research tool has been used to collect data on a patient’s 
perception of his/her symptoms, feelings of anxiety and future planning.  It was also used to 
collect data on the care giver’s knowledge on the patient’s problem, his/her confidence in 




The researcher designed the evaluation form (Appendix D), in collaboration with the 
research assistant.  The evaluation form allowed participants to give feedback on the 
research assistant and her role as programme co-ordinator, the extra visit to the doctor 
(which was part of the intervention), the value of the support group and the an overall 
impression of the programme.  The last question on the evaluation form asks for the 
participant’s opinion on the continuation of the programme and similar future initiatives 
(programmes with a focus on end-of-life care). 
In addition to this, MPCHC staff was asked to complete an evaluation form which the 
researcher designed for them (Appendix E).  This evaluation form aimed to assess the extent 
to which the staff in the clinic knew about the programme, their involvement in the 
programme, whether the programme made any difference to their daily work in the clinic 
and to what extent they thought it should continue, or alternatively be terminated (and, if so, 
why).  Permission to conduct this evaluation was obtained from the facility manager, 
operational manager and resident family physician.  Evaluation forms were given out to as 
many staff as were present at the clinic at the conclusion of the programme.   
 
Research assistant:  
The research assistant, Ms Yvonne Peterson, was not a healthcare professional.  She was a 
trained palliative care home-based carer.  She had completed the volunteer course at Saint 
Luke’s Hospice and had cared for her mother in the final stages of her life.  She thus had 
some experience in palliative care.  She had lived for many years in a community that makes 
use of the MPCHC as their primary healthcare facility, so she came from the same broad 
community as the patients in the study.  Her responsibilities included taking consent from the 
patients and their families, collecting the data as described above and convening the support 
groups.  The researcher trained the research assistant in the use of the data collection tools 
and explained to her the ethics of the research.  In her training, she was briefed on issues 
such as privacy and confidentiality, security of data and sensitivity in interacting with a 
vulnerable research population.  She was responsible for keeping records of the participants 
and keeping documentation locked in a cupboard at the facility.  Her position was funded by 
Hospice Palliative Care Association South Africa (HPCA). 
A desk was made available to Ms Peterson for the duration of the study.  The Health 
Promotion Officer’s room, where her desk was, was shared by a group of support staff in the 
clinic, who spent most of the week working in the community.  She was able to be in the 
same room and at the same desk each day for the duration of the study.  This room, although 
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shared by other staff members, was big enough that confidentiality could be ensured, by the 
appropriate use of screens.  Ms Peterson was easily accessible to staff and participants alike.  
The funding from HPCA covered the use of a cellular telephone, which Ms Peterson could 
use to make the telephone calls to collect data.  This telephone also allowed her to collect 
data after hours, if it better suited a particular participant.  She was able to make use of the 
short message service (SMS) to remind participants of a pre-set time for a conversation.  She 
was available to call participants during office hours on the cellular telephone, thereby not 
placing any extra burden on the CHC’s telephones.  This cellular telephone number was used 
by participants to contact her, if they had a problem that she, as programme co-ordinator 
could address.   
Ms Peterson assisted the participants in accessing healthcare in the facility.  At times she 
assisted in collecting their folders, occasionally keeping them company, while they waited 
for an appointment.  At other times she assisted them by organising help from the various 
health professionals in the CHC (e.g. by arranging an occupational therapy appointment for a 
patient with a stroke). 
 
Recruitment:  
Prior to the recruitment of participants, the clinicians (doctors and clinical nurse 
practitioners) at MPCHC were educated on the use of the Gold Standards Framework: 
Prognostic Indicator Guide, by the researcher.  At the time of the study there were five 
fulltime doctors and five temporary doctors completing their community service, all ten 
doctors were trained in the use of the Gold Standards Framework: Prognostic Indicator 
Guide.  In the same time period there were five full time clinical nurse practitioners, who 
were included in the training and recruitment of patients.  An amended version of the Gold 
Standards Framework: Prognostic Indicator Guide was used to identify patients who 
qualified for palliative care (Appendix A).  A copy of the amended version of the Prognostic 
Indicator Guide was placed in each consulting room and each clinical area of the CHC, to 
remind clinicians of the referral criteria.  The clinicians were asked to continue with their 
routine care and management of the patient.  Upon completion of their consultation, the 
clinician would inform the patient and care giver of the research study, then refer the patient 
and their family to the research assistant, who would provide them with the Information 
Letter (Appendix F) and be available to answer any questions they may have had.  Potential 
participants were assured that they could choose not to take part in the study or choose to 
withdraw from the study at any time.  Some participants gave consent immediately, while 
others decided to take the letter home, to talk to their family about participating, before 
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giving informed consent.  The research assistant took consent from all participants and 
family members.  If a patient took the letter home, the research assistant would arrange a 
time to call telephonically to follow up on their potential participation in the study.  The 
consent forms were returned the next time someone from the family was at the clinic.  Once 
consent was given, each participant was asked for personal information and some 
information on their recent illnesses.  All patients identified as needing palliative care during 
the study were invited to join the study.  The demographic information gave an indication of 
the extent of the need of palliative care in MPCHC and allowed the research assistant to 
invite all participants of the study to the support group.  
The researcher used convenience sampling to identify participants.  Recruitment for Group A 
commenced at the onset of the study (May 2012) and continued until more than 16 
participants were recruited.  The researcher chose to continue to recruit patients to Group A 
after 16 participants were recruited, to ensure that, despite potential dropout, there would still 
be sufficient participants to ensure that validity of the study.  Patients were recruited until the 
end of the week in which the 16th patient was recruited.  Participants who were approached 
for recruitment to Group A or Group B were given a second letter, which detailed the 
requirements of consenting to join Group A or Group B (Appendix G).  Each participant in 
Group A and Group B was asked to consent to the inclusion of a family member with their 
consent to join Group A or Group B.  Once the patient had given consent to involve the 
family member, the consent of the family member was also sought by the research assistant 
(Appendix H).  Signed consent forms were kept confidential by the research assistant, 
separate from the data which was collected. 
 
Data collection - Method:  
For six weeks, the research assistant applied the APCA African POS (Appendix C) to the 
participants and their family member (if consent has been granted), weekly.  The weekly 
interviewing of the patient and the interviewing of the family member were conducted 
separately from each other.  These interviews took place over the telephone or at the CHC, if 
the patient was at the facility.  No special visits to the clinic were required of the patients. 
Each patient was thanked, in person, after the collection of all the data, each week, and 
sincere gratitude and appreciation were expressed at the end of the six-week period.  After 
the completion of the programme, a folder review was conducted of all patients referred to 
the study.  This review was used to verify the information given by the participants, with 




Distress Protocol:  
In anticipation of the fact that participants may become too distressed to continue with data 
collection, during the course of the study, a distress protocol was put in place.  This involved 
the intervention of the social worker and clinical staff at the CHC, as required.  The distress 
protocol was never implemented, because the need for it did not arise.   
 
Abundant Life Programme Intervention:  
The programme was based on the Abundant Life Programme, at Victoria Hospital, in the 
suburb of Wynberg, which was then adapted for use in the primary healthcare setting.  After 
two and a half months of recruitment, 20 participants were recruited into Group A and data 
collection was close to completion.  At this point in time the intervention was initiated.   
With specialist input, it was decided that the intervention would consist of a regular support 
group and a specific consultation with a senior doctor to explain the patient’s prognosis and 
optimize their medical care.  The intention of the support group was to educate the 
participants and create a forum for information sharing, thus improving their health literacy 
regarding their conditions.  This was to be done with specialist input as described below.   
A support group met fortnightly at the facility from 1 August 2012 until 7 November 2012.  
A suitable room was found at the community resource centre in the neighbouring City 
Health Clinic, adjacent to the CHC.  The meeting of the support group was convened by a 
social worker, who was to be supported by a clinician, with invited professionals 
experienced in palliative care.  The support group was open to all members of the study 
population (i.e. patients identified with palliative care needs), not only participants of Group 
A or Group B. The support group only commenced at the onset of recruitment for Group B.  
Members of Group A had already completed their data collection and were invited from the 
initiation of the support group.  The research assistant invited participants of the study to join 
the support group and reminded them of dates and time of the support group.  
Meetings of the support group were convened from 14:00 to 15:00 on each of the following 
dates: 1 August 2012, 15 August 2012, 29 August 2012, 12 September 2012, 26 September 
2012, 10 October 2012, 24 October 2012 and 7 November 2012.  The meetings were held in 
the community resource centre, in a separate room from the City Health Clinic, behind 
closed doors, to ensure that no interruptions were experienced.  There were chairs and tables 
in the room, which were moved into a circle configuration for each meeting.  There was a 
kitchenette attached to the room, so tea and coffee could be served.  It was the research 
assistant’s responsibility to ensure that the room was booked for the meetings, that the room 
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was prepared for the meetings and that it was cleaned after the meetings.  Guest speakers 
were from St Luke’s Hospice, Kenilworth.  They included Ms Christilina Francis, a social 
worker, Sister Sharon Southerland, a palliative care nursing sister, Doctor Rene Krause, a 
palliative care specialist and the Reverend Peter Fox, a palliative care spiritual counsellor.  A 
guest speaker did not attend every support group meeting.  The sessions that were not 
attended by a guest speaker were used as an opportunity for the patients to share their 
experiences and difficulties with each other.  Each support group meeting was attended by 
between seven and eleven participants.  The composition of the groups varied over the 
course of the study, with between one and six patients present and between three and nine 
family carers present at any particular session. 
Group B participants were only recruited after most members of Group A had completed 
their data collection.  Group B patients were recruited from the newly referred palliative care 
patients in MPCHC.  They were not members of Group A, but were recruited from the same 
study population, so that had similar characteristics, as is shown in the Results chapter.  
From the point at which recruitment for Group B commenced, all patients referred to the 
research assistant were asked to join an intensive research group, Group B.  This recruitment 
of Group B continued until the end of the programme.  Once the patient had consented, they 
were asked if a family member could be included in the study and then the family member’s 
consent was sought.  Initially the patient and their family were given an opportunity to 
discuss their illness and problems with a clinician.  This consultation was not compulsory.  
Follow-up appointments with the clinician could be made as needed, or the patient was seen 
as normal in the CHC, by the various clinicians.  For six weeks from the date of recruitment, 
the research assistant applied the APCA African POS to the participants and their family 
members in Group B each week.  The weekly interviews of each patient and his/her family 
member were conducted separately from each other.  These were conducted over the 
telephone or at the CHC, if the patient was at the facility.  No special visits to the clinic were 
required of the patients.  The patients and their families were also invited to join the support 
group.  However, attendance at support group meetings was not compulsory for inclusion in 
Group B.  
The consultation and attendance at the support group were not compulsory, but the lack of 
attendance to both these aspects of the intervention impacted on the ability to compare the 
control group with the intervention group, as was the aim of this study.  Initially Group A 
was to be used as the control group and comparisons would have been analysed with the 
intervention group, Group B.  However, no participants from Group B attended the support 
group and only three participants visited the doctor as a part of the programme.  Participation 
in the intervention should have been part of the inclusion criteria for recruitment to Group B.  
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Due to the lack of participation of Group B in the intervention all the participants (patients in 
group A and group B) were analysed as one cohort, to assess the baseline palliative care 
needs in the study population and the change in these needs over time. 
At the end of six months, the study was terminated.  This time period had been estimated to 
be sufficient time to implement the programme and complete data collection.  By the time 
the study was terminated all of Group B’s data were collected.  As the study neared its’ 
completion, the researcher realised that there could be no comparison of the results of the 
APCA African POS between the intervention group and the control group, as the 
intervention group had not attended the intervention.  Thus assessment of the impact of the 
intervention could not be ascertained by means of the APCA African POS.  Another method 
of analysis was used, that of an evaluation of the programme, by participants and staff.  At 
the conclusion of the study, the evaluation forms were distributed (Appendix D).  The 
participants still in the programme at this point in time were asked to complete the form and 
return it to the research assistant.  The evaluation aimed to assess the effect that the 
programme had on participants and family members. 
The patients who had participated in the study were integrated back into the CHC, 
appropriate follow-up dates with clinicians were made and they continued to attend the CHC 
as they had before. They were thanked for their time and involvement in the research. 
At the time that the participants were completing an evaluation form, the staff in the clinic 
were also asked to complete an evaluation form (Appendix E).  Permission for this 
evaluation was granted by the Facility Manager and Operational Manager of the clinic.  
Evaluation of the programme was entirely voluntary.  The researcher asked as many staff 
members as possible to complete the forms and did not intrude on their work schedules.  The 
evaluation was conducted in an attempt to determine how the staff in the clinic perceived the 
programme and to ascertain the extent to which the programme had assisted them in their 
care of patients with advanced chronic illness. 
 
Storage, Safety and Confidentiality of Data:  
While the programme was running, documentation was stored at the facility, in a locked 
cupboard.  Since the termination of the programme, the documentation has been stored in a 
locked cupboard. 
The research assistant conducted each session with the patients and their care givers in 
private.  Each session’s data collection sheet bears only a number as identification.  The 
numbers correspond to codes assigned to the participants, recorded on a list kept separately 
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from the data collection sheets.  Only the researcher and the research assistant had access to 
the key to the codes, used for identification.  The data was been entered into the researcher’s 
personal computer, which was protected by means of a password. 
 
Data Analysis:  
All data was entered on a Microsoft Excel spreadsheet.   StataIC 12 was used to analyse all 
data.  As Group B did not participate in the intervention, the whole cohort was analysed 
together and there was no comparison of two separate means.  The APCA African POS data 
first underwent cross-sectional multivariate analysis.  P-values were derived from Chi-
squared tests or Fishers exact test if the expected frequency was below 5.  Multivariate 
analysis was used for large groups and T-tests were used to derive a P-value.  Cross-section 
time dependent regression analysis was applied to the data.  The evaluation forms were not 
statistically analysed, only reported on.    
 
Ethical Considerations: 
Ethical approval was obtained from the University of Cape Town (Appendix I – reference 
number 006/2012).  Permission to conduct this research study was obtained from the 
relevant managerial staff at the facility at which the research was conducted (i.e. MPCHC) 
and the MDHS Research Committee.  Informed consent was obtained from each participant 
and his/her care giver. Consent was obtained in the patient’s first language.  Refusal to 
participate did not subject patients to a standard of care lower than that which they had 
received previously at MPCHC.  
The researcher (a potential care provider at the facility) could not take the consent for this 
research.  This may have resulted in patients feeling an obligation to consent, even if they 
were assured that they could withhold consent.  The researcher wished to ensure that consent 
was given freely, not given under duress.  In the event of not consenting to participate in this 
study, the patient was still entitled to receive good medical care.  If the researcher had taken 
consent, patients may have felt that they would not receive the best medical care and so may 
have been pressured into giving consent.  The research assistant took consent for the study 
and collected the data.  
As this research involved a vulnerable sector of the population, it was taken into account that 
some patients may be more advanced in the stage of their illness than others.  If they did not 
wish to join the study, they still received good health care.  If, at any point in the study, they 
or their family members felt that they would like to withdraw from the study, they were free 
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to do so, without incurring the risk of suffering any negative consequences.  If the researcher 
or the research assistant felt that the participant was too ill to continue in the study, they 
would have been reminded that they were free to withdraw from the study.  However, at no 
point in this study did the research assistant, nor the researcher, feel the need to remind a 
participant that they could withdraw from an illness point of view.    
Some experts have debated the ethical validity of research in palliative care, as the people 
who need to be enrolled in such research are, by definition, nearing the end of their lives and 
hence their time is precious to them and their families74.  It has been agreed that, if evidence-
based medical practice for patients with palliative care needs is to be improved, research 
needs to take place.  However, there are some issues with research that should be taken into 
account.74  
In palliative care research, researchers are asking people who are near the end of their lives 
to be involved in a study that may or may not benefit them directly, and which will most 
likely take up valuable time and energy.  So, when designing such a study, researchers need 
to ensure the study has the potential to be of good value.  Researchers should be sensitive to 
the fact that they should not waste patients’ time and they should thus ensure that any study 
is comprehensive enough to have the potential to allow them to draw valid conclusions.  
Many people who are identified as needing palliative care and then invited to participate in 
such research may not survive long enough to experience the benefits of the study. This is 
unavoidable, but measures can be put in place to ensure they enjoy some of the potential 
benefits of the study.  It is worth remembering that not all research will have potential 
benefits, but it is hoped that this particular study will yield some benefits.  In palliative care 
research, researchers should endeavour to minimise the burden and risk to the patients who 
consent to participate in studies.74 
In this study, the researcher aimed to analyse a sample large enough to give credibility to the 
conclusions that would result from the analysis of the data.  However, the researcher was 
only able to recruit a few more participants than required, from a statistical analysis 
perspective.  The whole study population was invited to join the support group, so the 
intervention was not restricted to the intervention group.  The researcher made allowances 
for the collection of data telephonically, to reduce the need for participants to attend the 
clinic. The research tool was relatively quick to administer and therefore it was deemed not 
to be a major intrusion into the lives of the participants.  A distress protocol was formulated 
and put in place, to allow participants to withdraw from the study with the assurance that any 
patient or family member who became distressed would be offered counselling.  Consent to 
participate in this study was made freely, with no coercion, and the patient needed to be 
mentally competent to answer the APCA African POS questions.  Thus ethical issues 
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relating to consent were decreased.  Each time more data was collected, a verbal affirmation 
of continued consent was taken by the research assistant.  
As this programme involved the implementation of alternative care, not previously available 
at the MPCHC, consideration was given to what would / should happen at the facility once 
the study ended.  One of the outcomes of this project will be the compilation of a report (to 
be presented to the facility and the MDHS), which will outline the perceived benefits of this 
programme and recommend options for the provision of ongoing support for palliative care 
patients, either at the facility or facilitated by community or faith-based organisations.   All 
patients who participated in this study were integrated back into the facility, and it was 
ensured that they had a follow-up date with a clinician, as well as optimised medication.  





















CHAPTER 4: RESULTS 
This results chapter is divided into three sections.  In the first section, the results collated 
from the demographic information sheet are presented, and the study population is described.  
In the second section, the responses to the APCA African POS questions are presented and 
analysed.  The last section reports on the data gathered from the evaluation of the 
participants and the staff. 
 
DEMOGRAPHIC INFORMATION: 
This is the first section of the results chapter.  In this section, all information obtained from 
the demographic information sheets (Appendix B) is presented. 
 
Sample Characteristics: 
During the six months over which the study was conducted, 74 patients were referred from 
MPCHC and invited to consider participation in the study.  Of those, 46 (62.16%) consented 
to participate in the study. 
Demographic information for all participants included in the final sample is summarised in 
Table 1.  Overall, for the entire sample, the ages were not normally distributed (Shapiro Wilk 
p = 0.017).  The median age and the age ranges are therefore provided (mean age = 60.21 
years).  Individual age ranges, by sex, were normally distributed.  The mean age of the 
female patients was 60.92 years.  The median age and the range in ages are reported in Table 
1 (Shapiro Wilk p = 0.24).   The mean age of the male patients was 59.21 years.  The median 
age and the range in ages are reported in Table 1 (Shapiro Wilk p = 0.09).  When asked 











Table 1: Demographic Characteristics of Participants 
Sex  
        Female 27 (58.7%) 
        Male 19 (41.3%) 
Mean Age (in years) 61 (29-78) 
        Female 61 (36-78) 
        Male 61 (29-77) 
Diagnoses  
        Cardiac Failure only 7 (15.22%) 
        *COPD only 5 (10.87%) 
        **CVA only 7 (15.22%) 
        Cancer only 12 (26.09%) 
        Cardiac Failure and a CVA 2 (4.35%) 
        Cardiac Failure and Cancer 3 (6.52%) 
        COPD and Cancer 3 (6.52%) 
        Dementia 2 (4.35%) 
        #HIV positive 1 (2.17%) 
        Renal Failure 3 (6.52%) 
        COPD, Renal failure and a CVA                 1 (2.17%) 
Caregiver  
        Yes 42 (91.3%) 
        No 4 (8.7%) 
*COPD – Chronic obstructive pulmonary disease 
**CVA – Cerebro-vascular accident or stroke 
#HIV – Human immunodeficiency virus 
Participants reported their medical diagnoses.  These were then cross-checked against the 
folder review findings and the cross-checked results are reported above in Table 1.  The 
largest groups of different diagnoses were cancer only, cardiac failure only and one or more 
previous strokes only.  The most commonly occurring diagnoses were cancer only, cardiac 
failure only and one or more previous strokes only.   Of the 46 participants, 37 had only one 
diagnosis.  These participants had either cardiac failure, COPD, a previous stroke, cancer, 
dementia, HIV or renal failure.  Of those who had cancer (18), the specific types of cancers 
were lung cancer (3), gastric cancer (1), colon cancer (2), bone cancer (1), liver cancer (1), 
cervical cancer (2), prostate cancer (1), ovarian cancer (1), breast cancer (1) and pancreatic 
cancer (1).  There were 4 participants who did not state which type of cancer they had, and 
their folders could not be found in the folder review to verify the diagnosis or type of cancer.  
Participants who stated that they had cardiac failure and COPD were investigated in the 
folder review.  If their folder stated that, in fact, they did not have a diagnosis of heart 
failure, but rather a diagnosis of cor pulmonale, which is a complication of COPD and not 
left-heart failure (which is commonly referred to as heart failure), they were not added to the 




Table 2: Demographic Characteristics of Caregivers by Gender 
 Female Male Total 
Number of Caregivers 35 (83.33%) 7 (16.67%) 42 
Mean Ages 55 (25-81) 58 (41-74) 56 (25-81) 
Relationship of Caregiver to 
participant 
   
Child 11 (91.67%) 1 (8.33%) 12 (28.57%) 
Parent 3 (100%) 0 3 (7.14%) 
Relative 5 (100%) 0 5 (11.9%) 
Spouse 16 (72.73%) 6 (27.72%) 22 (52.38%) 
 
With regard to gender, female caregivers were in the majority (83.33%), as indicated in 
Table 2.   In this study all care givers were family members and not paid carers.   
All caregivers, described as relatives, were siblings and, as shown in Table 2, they were all 
female and therefore they were sisters of the patients.  For the remainder of this dissertation, 
caregivers will be referred to as “the family carer”.  In each case, the family carer was the 
person who consented to answer APCA African POS questions. 
Interactions with Health Care Facilities in the Preceding Six Months: 
Questions were asked of each participant about recent admissions (in the last six months) to 
a hospital in Cape Town, as well as visits to doctors or healthcare workers in Mitchells Plain.  
This information was cross-referenced with the folder review and comprehensive results are 
reported below. 
Visits to other clinics or outpatient departments in the last six months: 
Of the 46 patients who participated in this study, seven attended an outpatient appointment at 
a hospital in the last six months, all of which took place at GSH.  The mean age of those who 
attended GSH was 58 years, with the ages ranging from 29 to 77 years.  Of those who visited 
GSH, one participant had cardiac failure only, one had COPD, two (28.57%) had cancer, one 
had cardiac failure and a previous CVA, one had dementia and one had renal failure.   
The results shown in Table 3, for ages, institutions, diagnosis and family carer, all refer to 
those patients who were admitted in the last six months (56.52%).  The number reported 
under each institution is the number of participants admitted to that particular institution.  Of 
those who were admitted (26) compared to those who were not admitted (20), when 
compared by different diagnoses: Fisher’s exact: p = 0.57, which indicates that this 





Admissions to any hospitals in the last six months:  
Table 3: Recent Admissions to Hospital 
Yes 26 (56.52%) 
No 20 (43.48%) 
Mean Age  61 (29-78) 
Institutions:  
        GF Jooste Hospital 2 (7.96%) 
        Groote Schuur Hospital 20 (76.92%) 
        Mitchells Plain District Hospital 4 (15.38%) 
Diagnoses:  
        Cardiac Failure only 4 (15.38%) 
        COPD only 3 (11.54%) 
        CVA only 2 (7.69%) 
        Cancer only 9 (34.62%) 
        Cardiac Failure and a CVA 0 
        Cardiac Failure and Cancer 2 (7.69%) 
        COPD and Cancer 2 (7.69%) 
        Dementia 1 (3.85%) 
        HIV positive 1 (3.85%) 
        Renal Failure 1 (3.85%) 
        COPD, Renal failure and a CVA 1 (3.85%) 
 
Attendance at the 24 hour Trauma/Emergency Unit at the MP CHC in the last six 
months: 
Table 4 shows the details of those participants who attended MPCHC for an urgent problem, 
with no appointment.   
Table 4: Recent Visits to the Emergency Unit 
Yes 31 (67.39%) 
No 15 (32.61%) 
Number of times 2 [Range: 1 to 9] 
Mean Age 61 [Range: 29 to 78] 
Diagnoses:  
        Cardiac Failure only 4 (12.9%) 
        COPD only 4 (12.9%) 
        CVA only 2 (6.45%) 
        Cancer only 11 (35.48%) 
        Cardiac Failure and a CVA 1 (3.23%) 
        Cardiac Failure and Cancer 2 (6.45%) 
        COPD and Cancer 3 (9.68%) 
        Dementia 2 (6.45%) 
        HIV positive 0 
        Renal Failure 1 (3.23%) 




When analysing the above data, under the title “Number of times” the number is the mean 
number of times that each participant attended the emergency unit and the range of the 
number of visits is given in brackets. 
 
Other doctors:  
Of the 46 patients who participated in the study, only two (4.35%) visited another doctor 
outside the provincial health service and each of these was a General Practitioner (GP).  No 
reasons for these consultations were given.  Of the two patients who visited GPs, one had 
cancer and the other had cardiac failure.   
 
Community Health Centre: 
From the folder review, it could be determined how many times participants had attended 
MPCHC before the recruitment into the programme.  However, only 35 out of 46 folders 
were found in the folder review.  The attendance to MPCHC prior to the recruitment is 
tabled below: 
 
Table 5: Recent Visits to the CHC 
Yes 32 (91.43%) 
No 3 (8.57%) 
Number of times 1.9 (1-5) 
Mean Age 61 (29-78) 
Diagnoses:  
        Cardiac Failure only 4 (12.5%) 
        COPD only 5 (15.63%) 
        CVA only 7 (21.88%) 
        Cancer only 6 (18.75%) 
        Cardiac Failure and a CVA 2 (6.25%) 
        Cardiac Failure and Cancer 1 (3.13%) 
        COPD and Cancer 1 (3.13%) 
        Dementia 2 (6.25%) 
        HIV positive 0 
        Renal Failure 3 (9.38%) 
        COPD, Renal failure and a CVA 1 (3.13%) 
 
The mean number of times a participant attended MPCHC is reported in Table 5, with the 
range of times in brackets.  The folder review was able to show which patients still attended 
MPCHC or MPDH after recruitment to the programme and how many times they attended.  
These results can be found in Table 6.  
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Table 6: Visits to the MPCHC After Recruitment to the Programme 
Yes 25 (71.43%) 
No 10 (28.57%) 
Number of times 1.32 (Range 1 to 3) 
  MPCHC 1.4 (1-2) 
  MPCHC Trauma 1.2 (1-3) 
  GSH 1.5 (1-2) 
Average Age 61 (29-77) 
Diagnoses  
        Cardiac Failure only 4 (16%) 
        COPD only 5 (20%) 
        CVA only 3 (12%) 
        Cancer only 7 (28%) 
        Cardiac Failure and a CVA 2 (8%) 
        Cardiac Failure and Cancer 0 
        COPD and Cancer 0 
        Dementia 1 (4%) 
        HIV positive 0 
        Renal Failure 2 (8%) 
        COPD, Renal failure and a CVA 1 (4%)  
 
RESULTS FOR GROUP A AND GROUP B: 
In this section of this  chapter, the results relating to the control group (Group A) and the 
intervention group (Group B), and the data collected by means of the APCA African POS 
(Appendix C) data collection tool are presented.  
Demographics for Group A and Group B: 
Of the 46 patients who participated in this study, five were excluded from the collection of 
data through the APCA African POS as a result of the fact that they had dementia or 
struggled with communication problems.  The remaining 41 participants were recruited into 
either Group A or Group B.  Group A was, in essence, the control group, and consisted of 
twenty patients, recruited over a period of three months, from the time at which the 
programme was initiated.  Group B, which was intended to be the intervention group, 
consisted of patients who were recruited after most patients in Group A had completed their 








Table 7: Demographics of Group A and Group B 
 Group A  Group B  
Gender   p = 1 
       Females 11 (55%) 12 (57.14%)  
       Males 9 (45%) 9 (42.86%)  
Mean Age (years) 61.5 (53-77) 61 (29-78) p = 0.22 
Diagnoses:   p = 0.49 
       Cardiac failure 3 (15%) 4 (19.05%)  
       COPD 4 (20%) 1 (4.76%)  
       CVA 4 (20%) 2 (9.52%)  
       Cancer 3 (15%) 7 (33.33%)  
       Multiple Co-Morbidities 6 (30%) 7 (33.33%)  
Family Carer   p=0.34 
       Yes 17 (85%) 20 (95.24%)  
       No 3 (15%) 1 (4.76%)  
Relationship of Family Carer   p = 0.25 
      Children 5 (29.41%) 4 (20%)  
      Parent 0 3 (15%)  
     Relative 1 (5.88%) 4 (20%)  
     Spouse 11 (64.71%) 9 (45%)  
Family Carer’s Gender   p = 0.38 
     Female 13 (76.47%) 18 (90%)  
    Male 4 (23.53%) 2 (10%)  
Died   p = 0.004 
      Survived 16 (80%) 7 (33.33%)  
      Died during study 4 (20%) 14 (66.67%)  
Support Group 12 (60%) 0  
Visit to Doctor 0 7  
     During study 0 3 (14.29%)  
     End of study 14 (70%) 4 (19.05%)  
 
In Group A, the age distribution was normal (Shapiro Wilk: p = 0.27).  The mean age and the 
range in ages are reported in Table 7.  In Group B the age distribution was normal (Shapiro 
Wilk: p = 0.14).  The mean age and the range in ages are reported above.  The age ranges for 
Group A and Group B were compared using the Wilcox rank-sum test (p = 0.33). 
Within the category of diagnoses, the researcher deemed that some groups were too small to 
allow meaningful statistical analysis, so those participants with more than one diagnosis 
were grouped together under the heading “Multiple Co-morbidities”.  
Of the entire cohort (41 participants), twelve (29.27%) chose to attend one or more support 
group meetings and 29 (70.73%) chose not to attend a support group meeting.  The number 
of different families from whom a member attended one or more support group meetings 
was thirteen.  One family, in which the patient was excluded from Group A and B, based on 
the fact that he/she had dementia, did in fact attend a support group meeting.  Of the thirteen 
families from whom a member attended one or more support group meetings, six different 
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patients attended meetings, with a mean attendance of 2.17  meetings (ranging from one to 
five) and 10 family carers attended, with a mean attendance of  2.9 meetings (ranging from 
one to six).  From Group A, twelve patients (60.00%) attended one or more support group 
meetings after completion of the APCA African POS and eight (40.00%) did not attend any.  
From Group B, no participants attended a support group meeting.  This has been mentioned 
previously and it is one of the reasons why the whole cohort (Group A and Group B) was be 
analysed together.  No APCA African POS results were collected for the patients in Group A 
who attended one or more meetings of the support group, after attending of the meeting(s).  
This was because they only attended the support group after the completion of their APCA 
African POS data collection.  The evaluation of the support group by patients assigned to 
Group A is the only feedback available for the support group.  This evaluation is presented 
later in this chapter. 
The patients assigned to Group A were invited to attend a consultation with a doctor, after 
collection of the APCA African POS data was completed.  Fourteen patients (70.00%) took 
advantage of this opportunity.  Of the twenty-one patients assigned to Group B, fourteen 
(66.67%) never took advantage of the opportunity to attend the consultation offered to them, 
three (14.29%) attended a consultation during the study and four (19.04%) attended a 
consultation at the end of the study.  The group that attended a doctor’s consultation during 
the study is analysed below (Figure 4). 
As stated in the chapter on methodology, as a result of the fact that only three participants 
assigned to Group B participated in the intervention, the entire cohort was analysed together, 
based on variables that were found to be statistically significant. 
As indicated in Table 7, with regard to the number of participants who died during the study, 
significantly more deaths occurred among the patients assigned to Group B, compared to 
those assigned to Group A.  The event “dying during the study” is further analysed in Table 
8.  Comparing those who survived with those who died during the study, by gender, analysis 
yielded a p-value of 0.49.  Given that the p-value is greater than 0.05, this analysis is not 
shown.  Table 8 shows the comparison of the time of death of patients assigned to Group A 
and Group B, in relation to the time at which they joined the study.  A distinction is made 
between “before three completed weeks” and “after three completed weeks”, as the 






Table 8: Comparison of patients who died before three completed weeks and those who 
died after three completed weeks 
 Group A Group B  
Survived 16 (80%) 7 (33.33%)  
Died during the study 4 (20%) 14 (66.67%)  
           Before 3 weeks 1 (5%) 12 (57.14%)  
           After 3 weeks 3 (15%) 2 (9.52%)  
   p = 0.001 
 
APCA African POS Data: 
APCA African POS data was collected at week zero, and then weekly for the six weeks 
following the date of the initial data collection.  The data has been analysed at different times 
by different variables.   
All the Figures showing the APCA African POS results use an abridged version of the 
questions (Appendix C).  The same format is used throughout this document.  All scores are 
integral values on a scale from zero to five.  For the first three questions, zero represents “no 
pain or symptoms” and five represents “the worst symptoms they have ever felt”.  For the 
other six questions, zero represents a very negative response and five represents the most 
positive feeling, with regard to each question. 
Figure 1 shows the whole cohort summarised for all APCA African POS responses at week 
zero.  Table 9 shows the numbers of respondents (N), the mean value of responses, with 




Figure 2: APCA African POS responses at week zero (entire cohort) 
 
Table 9: Statistics represented in Figure 2 
 N mean min max 
Pain 41 2.34 0 5 
Symptoms 40 1.73 0 5 
Worry  38 2.58 0 5 
Sharing 39 4.23 0 5 
Worth 34 3.59 0 5 
Peace 36 3.47 0 5 
Planning 21 4.29 0 5 
Information 36 3.91 2 5 
Confidence 36 4.08 2 5 
Worried 36 3.33 0 5 
 
As indicated in Table 7 there was a significant difference in the attrition rate exhibited by the 
patients in Group A compared with that exhibited by the patients in Group B.  The patients 
in Group B exhibited a significantly higher attrition rate than those in Group A.  Based on 
this observation, a comparison of those participants who died during the study and those who 
survived was carried out.  Analysis of the APCA African POS results from the patients who 
survived and those who died during the study, in Group A and Group B yielded a p-value of 














Figure 2 shows a comparison of the APCA African POS results, for the whole cohort, 
divided into two groups: those participants who died and those who survived until the end of 
the study.   
 
Figure 3: APCA African POS results at week zero, for participants who survived the 
study compared with participants who died during the study 
 
Table 10: Statistics represented in Figure 3 
 Completed  the Study Died during the Study  
 N mean min max N mean min max p value 
Pain 23 2.04 0 5 18 2.72 1 4 0.049 
Symptoms 22 1.82 0 5 18 1.61 0 5 0.36 
Worry  20 2.55 0 5 18 2.61 1 4 0.023 
Sharing 21 4.19 0 5 18 4.28 2 5 0.54 
Worth 16 4.06 2 5 18 3.17 0 5 0.024 
Peace 20 3.6 0 5 16 3.31 2 5 0.25 
Planning 12 4.33 2 5 9 4.22 0 5 0.15 
Information 19 4.21 2 5 17 3.59 2 5 0.012 
Confidence 19 4.26 3 5 17 3.88 2 5 0.16 
Worried 19 3.26 0 5 17 3.4 1 5 0.77 
 
Some participants died before their third completed week of the study, and others died after 















numbers of patients in Group A and Group B, comparing those who survived and those who 
died before or after three completed weeks yielded a p-value of 0.001, which means that 
there is a statistically significant difference between those that survived the programme and 
those that died during the programme  When the responses to the APCA African POS of the 
two groups were analysed, there were four questions for which the responses from those 
patients who died before three completed weeks exhibited a statistically significant 
difference from the response of those patients who completed the study.  The questions are 
those relating to “pain”, “worry”, “worth” and “information”.   
Note that “pain” related to how severe the person’s pain was in the three days prior to the 
date of data collection.  These results show that those who died during the study reported 
feeling more severe pain than those who survived the study (p = 0.049).  The mean “pain” 
score for patients who survived was 2.04 and the mean “pain” score for patients who died 
was 2.72.  Those who died during the study reported a smaller range of pain responses 
compared to those that survived the study.   
The “worry” indicator relates to the patient’s worry over their illness in the three days prior 
to the date of data collection.  These “worry” scores for the two groups of patients are 
significantly different (p < 0.05), with a mean score of 2.55 for the patients who survived and 
a mean score 2.61 for the patients who died.  Half (50%) of the patients who died during the 
study had a response of 2 or 3 out of 5.   
The “worth” indicator relates to a how worthwhile the patient has felt their life to be in the 
three days prior to the date of data collection.  The mean “worth” scores were 4.06 for the 
group of patients who survived and 3.17 for the group of patients who died (p = 0.024).  
Patients who survived the study reported “worth” scores of 4 or 5, out of 5, while patients 
who died during the study reported “worth” scores of 3 or 4, out of 5.  Analysis of these 
scores suggests that the group of patients who survived the study felt their lives were more 
worthwhile than those that died during the study.   
The final score which displayed a significant difference related to the question on 
“information”, where the family carer was asked if they felt they had received enough 
information about the patient’s illness.  The family carers of those participants who died 
before three completed weeks reported a mean score of 3.92 (with a range of 3 to 5, where 5 
represents “as much as we wanted”).  In the group of patients who survived the study, the 
mean score was 4.21 (with a range of 2 to 5).  Analysis of these scores suggests that the 
families of those that survived the study seemed to have been more content with the 




The scores associated with all of the other responses displayed no statistically significant 
difference between the two groups (p > 0.05). 
Comparison of the number of participants who died before three weeks and those who died 
after three weeks, by Group A and Group B yielded a p-value of 0.044.  Comparison of the 
numbers of participants that survived and those that died after three weeks (combining 
Group A and Group B) yielded a p-value of 0.001.  This indicates that there is a statistically 
significant difference between the numbers of participants who died before three weeks and 
those that died after three weeks and the comparison of those that survived the programme 
and those that died after three completed weeks is also statistically significant.  However, 
when detailed analysis of the APCA African POS data was perfomed, comparing scores for 
the group of patients who died before three completed weeks and scores for the group of 
patients who died after three completed weeks, only one question was found to yield scores 
that were statistically significantly different in the two groups.  It was the score relating to 
“information”, based on a question asked of the family carer, relating to how much 
information the family had received about the patient’s illness.  In the group of patients who 
died before three completed weeks, the mean score was 3.92 (with a range of 3 to 5, with 5 
representing the answer “as much as we wanted”).  In the group of patients who had died 
after three completed weeks, the mean score was 2.8 (with a range of 2 to 3).  Comparrison 
of the scores suggested that they were statistically significantly different (p = 0.006).  
Statistical analysis of the responses to the other nine questions indicated that they were not 
statistically significantly different (p > 0.05). 
Analysis of the responses to the APCA African POS was performed with the scores grouped 
based on the different diseases, assessing the impact of different diseases on the burdens of 





Figure 4: Comparison of APCA African POS results by different disease categories 
Table 11: Statistics represented in Figure 4 
 Cardiac Failure COPD CVA 
 N Mean Min Max N Mean Min Max N Mean Min Max 
Pain 7 2.29 0 5 5 2 0 4 6 2 0 4 
Symptoms 7 1.29 0 5 5 2.2 0 5 6 1.83 0 4 
Worry  7 2.14 0 5 5 3.4 2 5 5 2 0 5 
Sharing 7 4.43 3 5 3 5 5 5 6 4 0 5 
Worth 4 3.25 3 4 5 4.4 4 5 4 4.25 3 5 
Peace 6 3.33 3 4 4 4.25 2 5 5 3 2 5 
Planning 3 5 5 5 1 5 5 5 3 3 2 5 
Information 6 4.33 3 5 4 4.25 3 5 6 4 2 5 
Confidence 6 4.5 3 5 4 4.5 4 5 6 4.17 3 5 
Worried 6 3.5 1 5 4 3.25 3 4 6 3.5 2 5 
 
 Cancer Multiple co-morbidities p-values 
 N Mean Min Maxx N Mean Min Max  
Pain 10 3.2 1 5 13 2 0 4 0.43 
Symptoms 9 2.89 0 5 13 0.92 0 3 0.05 
Worry  9 2.78 1 5 12 2.58 1 4 0.53 
Sharing 10 3.9 0 5 13 4.31 3 5 0.74 
Worth 9 3.11 0 5 12 3.5 2 5 0.20 
Peace 9 3.22 0 5 12 3.67 2 5 0.59 
Planning 7 4 0 5 7 4.71 3 5 0.35 
Information 9 3.56 2 5 11 3.18 3 5 0.51 
Confidence 9 3.89 2 5 11 3.81 3 5 0.45 






















In order at ascertain if there are differences in responses to the APCA African POS tool 
across the disease spectrum, an analysis of the APCA African POS responses was 
performed.  This analysis is presented in Figure 4 and Table 11.  The only statistically 
significant difference is for the question on symptoms, where the p-value was 0.05.  When 
the responses for symptoms was further analysed it was found that the comparison between 
cancer and multiple co-morbidities shows a p-value of 0.042 (implying statistical 
significance with a p-value < 0.05), all other comparisons for symptoms, between different 
disease categories, has a p value of 1. 
 
Cross section time dependent regression analysis: 
In order to ascertain if the data fitted a statistical pattern, cross section time dependent 
regression analysis was applied to the data, using all participants as one cohort.  
For the questions on pain, sharing, worth, peace, planning, information, confidence and for 
the final question around worry; the analysis for each question was not statistically 
significant. 
For the question on symptoms: “Have any other symptoms been affecting how you feel in 
the last three days?” the responses ranged from 0 to 5, with a mean score of 1.73  in week 
zero and  a mean score of 2.53 in week six.  A score of zero represents no symptoms and 5 
represents overwhelming symptoms.  This data had a coefficient of 0.37, with a p-value of 
0.039.  The increase from 1.73 to 2.53 is a significant increase in symptom burden. 
“Have you been feeling worried about your illness in the last three days?” is represented 
under the heading “worry”.  The response of cohort ranged of from 0 to 5, with a mean score 
of 2.58 in week zero and a mean score of 3.25 in week six.  A higher score indicates more 
worry.  This analysis has a coefficient of 0.36 and a p-value of 0.018.  The increase from 
2.58 to 3.25 is a significant increase in worry over their illness. 
The scores of the participants who did visit the doctor, as part of the intervention, were 
analysed with cross section time dependent regression analysis.  The results are shown in 
Figure 5 with the relevant statistics and coefficients in Table 12.  This analysis will be 




Figure 5: Participants who attended the doctor’s consultation, week zero compared to 
the visit after the consultation 
 
Table 12: Statistics represented in Figure 5 
 Week 0 After visit with the Doctor   
 N mean min max N mean min max Coefficient P value 
Pain 3 3.33 2 4 3 4.33 3 5 0.14 0.194 
Symptoms 3 3 3 3 3 3 2 5 0 1 
Worry  3 3 3 3 3 4.33 4 5 0.19 0.00 
Sharing 3 4 3 5 3 4.67 4 5 0.095 0.27 
Worth 3 3.33 2 5 3 4 3 5 0.095 0.44 
Peace 2 4 3 5 3 3 1 4 -0.14 0.39 
Planning 1 4 4 4 2 4.5 4 5 - - 
Information 2 4 3 5 2 5 5 5 0.143 0.16 
Confidence 2 4 4 4 2 5 5 5 - - 











Pain Symp Worry Sharing Worth Peace Plan Info Conf Worried
Week 0 After visit with Doctor
55 
 
EVALUATION OF THE PROGRAMME: 
This final section of the results chapter presents data relating to the evaluation of the 
programme by the participants and the clinic staff (using the instruments presented as 
Appendix D and E).  This evaluation was conducted once the study programme ended. 
Evaluation by participants: 
Participants, who were still alive and in contact with the coordinator of the programme at the 
end of the study, were asked to complete an evaluation form.  There were questions on the 
role of the coordinator, the patient’s visit to the doctor, attendance at the support group 
meetings and questions on the patients’ opinions regarding the future of the programme and 
potential continuation of such an intervention.  (Refer to Appendix D for the evaluation 
form.) 
Twenty participants completed the evaluation form.  Ten were patients and ten were 
caregivers or family members.  It was not stated if any of the respondents were related to 
each other. 
The coordinator: 
The overall impression of the coordinator, reported by the patients, with regard to their 
experience in the CHC, was that she (the coordinator) was helpful.  One person indicated 
that she was of “some help”, twelve (60%) indicated that she was “helpful” and seven 
participants (35%) indicated that she was “very helpful”. 
The question “In what ways did she assist you?” was asked in the evaluation form, options 
were presented and answers of “not really”, “sometimes” and “yes” were offered.  Figure 5 
show those a summary of the responses from the participants.  
 
Figure 6: Ways in which the coordinator assisted participants 
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Two comments made by participants under this section of the evaluation were that the 
coordinator was “very pleasant” and “made me feel very relaxed”.  When asked if they 
would like this role of coordinator to continue 13 participants (81%) responded with “yes” 
and three participants (19%) stated “definitely”.  Only 16 respondents answered this 
question. 
The visit to the doctor:  
Eleven participants (58%) stated that they did remember the doctor they visited as part of the 
programme, while eight out of 19 respondents (42%) did not remember the doctor.  All the 
doctors mentioned in the responses were male doctors, so the pronoun “he” will be used 
below in reference to the doctor concerned.  When asked if the doctor explained what was 
wrong with them, all participants who responded to this question (i.e. 17) stated that he did 
explain to them what was wrong.   
When asked if the doctor answered their questions, one participant answered “not really”, ten 
(52.6%) answered “mostly”, five (26.3%) answered “yes” and three (15.8%) stated that he 
had answered all of their questions. 
When asked if the doctor tried to make them feel better, three participants (15.8%) answered 
“not really”, eight (42.1%) answered that he tried, five (26.3%) answered “yes” and three 
(15.8%) answered that he had made a difference. 
When asked if the doctor improved their quality of life, three participants (15.8%) answered 
“not really”, 11 (57.9%) answered that he had tried, two (10.5%) answered “yes” and three 
(15.8%) answered that he had made a difference. 
When asked how helpful the discussion (consultation) was to how they were feeling at the 
time of completing the evaluation, one participant (5.3%) stated that it was not helpful, two 
(10.5%) stated that it had helped a bit, five (26.3%) answered that it had helped, seven 
















Figure 7: Responses to questions about the visit to the doctor 
The support group: 
Of the 19 participants who responded to the question on attendance at a meeting of the 
support group, 17 participants (89.5%) had attended at least one session.  The comments 
from the two who did not attend a meeting were that they had “no transport” and “no time” 
respectively.  Of those who attended, four (23.5%) participants came once, eight (47%) came 
twice, four (23.5%) came three times and one (5.9%) came four times.  In response to the 
question regarding the continuation of the support group, all 18 (100%) respondents who 
answered this question said they would like it to continue.  The participants were asked 
about what aspects of the support group they found helpful.  Figure 7 shows the responses to 
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Figure 8: Responses to what aspects of the support group the participants felt were 
helpful 
With regard to the continuation of the support group, 100% of the respondents stated that 
they would like it to continue.  When asked about preference of venue, if the support group 
were to continue, 17 respondents (89.5%) stated that the CHC was a preferable venue, while 
two respondents (10.5%) stated that a venue in the community would be better.  When asked 
about how often the support group should meet, if it were to continue, two respondents 
(11.8%) stated that every two months would be preferable, 14 (82.4 %) stated that monthly 
would be preferable and one stated that fortnightly would be preferable. 
In summary, there were a few questions about the whole programme.  The respondents were 
asked if they would like the programme to continue or not.  All 20 participants (100%) stated 
that they would like the programme to continue.  When asked if there should be any changes, 
one respondent said that there should be changes, but did not state what those should be and 
17 (94.4%) said that there should be no changes.  When asked if they had recommended the 
programme to other people, 12 respondents (63.2%) stated that they had already 
recommended it and seven (36.8%) stated that they had not.  When asked if they would 
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Staff at the CHC were asked to evaluate the programme.  Some staff were involved in 
different aspects of the programme and others were not.  There were 37 staff members who 
completed a form (Appendix E). Table 15 presents the breakdown of the staff members who 
completed the evaluation, with staff divided into different job categories. 
Table 13: Job categories of staff respondents for the staff evaluation 
Administrator 1 (2.7%) 
Clinical Nurse Practitioner (CNP) 6 (16.2%) 
Doctor 8 (21.62%) 
Enrolled Nurse (EN) 6 (16.2%) 
Enrolled nursing assistant (ENA) 3 (8.11%) 
Health Promotion officer (HPO) 2 (5.4%) 
Operational manger 1 (2.7%) 
Registered nurse (RN) 10 (27.03%) 
Total 37 (100%) 
 
For purposes of analysis, the clinical nurse practitioners and doctors were grouped together 
under the heading “clinicians”.  The registered nurses, enrolled nurses and operational 
manager were grouped together under the heading of “nurses”.  The enrolled nursing 
assistants, health promotion officers and administrator were grouped together under the 
heading of “other”.  
When the staff members were asked if they knew about the programme, 29 respondents 
(78%) indicated that they did know about the programme and eight (22%) indicated that they 
did not know about the programme.   
Table 14: Staff response to questions on knowledge of the programme 
 Yes No 
Clinicians 13 (92.9%) 1 (7.1%) 
Nurses 12 (70.6%) 5 (29.4%) 
Other 4 (66.7%) 2 (33.3%) 
 
When asked if they had been involved with the programme, 21 staff members (56.8%) said 
they had been involved and 16 (43.2%) said they had not been involved.  The responses to 




Table 15: Ways staff members were involved in the programme 
 Clinicians  Nurses  Other  Total  
As a patient/family 1 (7.1%) 0 0 1 (2.7%) 
Referred patients to programme 12 (85.7%) 9 (52.9%) 3 (50%) 24 (64.9%) 
Seen patients as part of the 
programme 
2 (14.3%) 1 (5.9%) 0 3 (8.1%) 
Assisted the co-ordinator with 
queries 
4 (28.6%) 2 (11.8%) 2 
(33.3%) 
8 (21.6%) 
Attended a support group 0 0 0 0 
Total 14 17 6 37 
 
When asked if they had referred a patient, 26 staff members (72.2%) indicated that they had 
referred a patient and 10 (27.8%) indicated that they had not referred a patient. 
 Table 16: Staff response to if they had referred a patient to the programme or not 
 Yes No 
Clinicians 11 (84.6%) 2 (15.4%) 
Nurses 11 (64.7%) 6 (32.3%) 
Other 4 (66.7%) 2 (33.3%) 
 
When asked if they knew which patients to refer to the programme (i.e. what the referral 
criteria were), 26 staff members (70.3%) indicated that they did know which patients to refer 
and 11 (29.7%) indicated that they did not know which patients to refer. 
 Table 17: Staff response to knowledge of which patients to refer to the programme 
 Yes No 
Clinicians 12 (85.7%) 2 (14.3%) 
Nurses 10 (58.8%) 7 (41.2%) 
Other 4 (66.7%) 2 (33.3%) 
 
In response to the question on barriers in referral to the programme, four staff members 
(11.4%) stated that there were barriers and 31 (88.6%) said there were not.  Comments made 
on the topic of barriers to referral include “I didn't have any knowledge about it.” and 
“Working in trauma, there is little time for interaction with the [patients].” 
Table 18: Staff responses to barriers in referring patients to the programme 
 Yes No 
Clinicians 1 (7.1%) 13 (92.9%) 
Nurses 2 (12.5%) 14 (87.5%) 




When asked if they had met the coordinator, 25 staff members (73.5%) indicated that they 
had met her and nine (26.5%) staff indicated that they had not met her. 
Table 19: Staff responses to having met the programme coordinator or not 
 Yes No 
Clinicians 10 (83.3%) 2 (16.7%) 
Nurses 11 (68.8%) 5 (31.2%) 
Other 4 (66.7%) 2 (33.3%) 
 
When the staff were asked if they had ever asked the coordinator to assist with patient care, 
of patients not necessarily part of the programme, 11 respondents (33.3%) said they had 
asked for her help and 22 (66.7%) said they had not asked her. 
Table 20: Staff response to asking the coordinator to assist with patient care, of patients 
not necessarily in the programme 
 Yes No 
Clinicians 4 (33.3%) 8 (66.7%) 
Nurses 6 (37.5%) 10 (62.5%) 
Other 1 (20%) 4 (80%) 
 
In response to the question on the extent to which the programme had had an impact on 
them, there were 30 responses from the staff.   
 Table 21: Staff response to the question of degree of impact the programme had on 
them 
No impact 4 (13.3%) 
Minimal impact 6 (20%) 
Some impact 13 (43.3%) 
A large impact 7 (23.3%) 
 
Table 22: Staff response to the question of degree of impact the programme had on 
them 







Clinicians 0 4 (33.3%) 7 (58.3%) 1 (8.3) 12 
Nurses 4 (28.6%) 2 (14.3%) 3 (21.4%) 5 (35.7%) 14 







Some of the comments regarding the impact of the programme follow. 
“Could refer chronic patients for some assistance or better management.” 
“It made me realise the importance of supporting the family members with chronic 
diseases.” 
“[It] assisted with more options with patient care.” 
“It improved the quality of life for the patients I referred.” 
“[There are] a lot of old people staying at home without any assistance.” 
“Because we see less of the palliative patients in trauma.” 
“It has shown me that this programme is actually necessary for people who are terminally ill 
and their families.” 
“Had a referral person on site - made it so much easier.” 
“It helped a lot of people that there is no treatment for anymore” 
“Because you don't need to send patients to hospital that are end-stage.” 
“Makes our work lighter.” 
“Raised the awareness of palliative care facilities in Mitchells Plain.” 
 
When asked if this programme should continue, 31 respondents (96.9%) said it should and 1 
(a clinician) said it should not.   
The following comments were made with regard to continuing the programme. 
“The hospital needs it.” 
“If it is assisting the community in a positive manner it should proceed.” 
“There is a need for palliative care, especially in this CHC.” 
“Very helpful and supportive.” 
“To help the family with counselling and move forward.” 
“To help the clients understand their illness better.” 
“It gives patients hope.” 
“Shows the patient that being sick does not mean the end of the world.” 
“Less palliative care patients in trauma.” 
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“It is a great help to the staff because they can refer clients who need extra help, because 
they do not have enough time.” 
“There is a need for patients and family members to have support and counselling.” 
“A large number of clients fit the criteria for referral and need more care than just visiting a 
health care centre.” 
When asked if they would like to be more involved in the programme, if it were to continue, 
20 respondents (74%) indicated that they would like to be more involved and 7 (26%) 
indicated that they would not like to be more involved.  
Table 23: Staff responses to being more involved in the programme, if it were to 
continue 
 Yes No 
Clinicians 6 (60%) 4 (40%) 
Nurses 11 (78.6%) 3 (21.4%) 
Other 3 (100%) 0 
 
In response to the question on whether they would like more information, 29 respondents 
(87.9%) indicated that they would like more information and 4 (12.1%) indicated that they 
would not.  
Table 24: Staff responses to getting more information 
 Yes No 
Clinicians 9 (75%) 3 (25%) 
Nurses 14 (93.3%) 1 (6.7%) 
Other 6 (100%) 0 
 
In response to the question on whether they would like more palliative care training, 24 
respondents (77.4%) indicated that they would like more training and 7 (22.6%) indicted that 
they did not want more training.  
Table 25: Staff responses to wanting more palliative care training 
 Yes No 
Clinicians 7 (58.3%) 5 (41.7%) 
Nurses 13 (92.9%) 1 (7.1%) 







CHAPTER 5: DISCUSSION 
 
The aim of this study was to evaluate and compare patient-reported outcomes, reported by 
patients deemed to be in need of palliative care, prior to an intervention, and then with a 
palliative care-based intervention in place.  The data obtained prior to the intervention, to 
evaluate the participants, was deemed satisfactory.  However, participation by participants in 
the intervention programme was suboptimal, and the researcher was unable to use the APCA 
African POS to compare patient-reported outcomes recorded before the intervention was in 
place with patient-reported outcomes recorded once the intervention was in place.  The 
researcher was able to evaluate the effect of the intervention on the participants by means of 
a participant and staff evaluation form, focusing on the intervention. 
 
Recruitment of participants: 
Of the 74 patients referred to the study, only 46 consented to participate in the study.  Of the 
28 that did not consent, some were lost to follow-up and could not be contacted for a 
response.   
Some of those who were contacted stated that they did not need any extra help or that they 
had enough support from other sources.  In certain cases (fewer than ten), the researcher 
found that the patient’s family members had played a role in influencing the patient’s 
decision not to participate in the study.  A few of these families did not want their loved 
ones, nor themselves, to be involved in the programme.  It appeared that families who did 
not proactively discourage the patients from participating in the programme, were unhelpful 
and unsupportive when the patient was deciding whether or not to participate in the 
programme. 
In order to create a control group for this study, and to determine the burden of symptoms 
that this group of people with palliative care needs experience, the researcher opted to start 
this research project without telling the patients that they had been identified as being in need 
of palliative care, they were only told that the study was for people with chronic illnesses.  
Informing the patients that they were in need of palliative care because they were nearing the 
end of their lives (i.e. “breaking the bad news”) was incorporated into the research project, to 
be done at the consultation with the doctor, either at the end of the collection of the APCA 
African POS data, in the case of Group A, or during the collection of the APCA African POS 
data, in the case of Group B.  From the perspective of the medical staff, it was felt that 
asking the clinician, who was referring the patient, to “break the bad news”, would increase 
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the clinician’s workload, and this may become a barrier impeding referral to the programme.  
All clinical staff were given the same referral criteria and the same instructions on how to 
refer patients to the programme.  However, other palliative care programmes in Cape Town 
(Abundant Life and St Luke’s Hospice programmes) have criteria for referral which state 
that the person in need of palliative care must be told of the prognosis, i.e. the person doing 
the referral must “break the bad news” to the person and family, and then obtain the patients 
consent, before referring them to the programme.  Without this consent, the two programmes 
mentioned will not get involved in the care of the patient.   
There may have been different responses from the patients involved in this study, if the 
protocol had required that the intervention begin with the consultation, “breaking the bad 
news” and optimising care, before referring the patients to the programme co-ordinator.   
Demographic differences: 
There was a wide age range in the ages of the participants and although the ages were not of 
a normal distribution, the difference between the mean and the median (60.21 years and 61 
years, respectively) was very similar.  There was a patient who was excluded from the study, 
because she was younger than 18 years.  This illustrates the wide range in the ages of the 
people in need of palliative care.  This age distribution also shows the extent to which 
younger people are in need of palliative care.  The focus of this study was on chronic 
diseases, but not all people with chronic diseases are elderly.  However, the mean age of 
patients involved in this study was 61 years.  By way of comparison, Van Niekerk and 
Raubenheimer found the mean age in their study to be lower, at 48 years23.  
Mitchells Plain, the suburb in which the study was set, is traditionally an area inhabited by 
coloured South African people.  People who were moved from District Six and other areas, 
which were classified as ‘white’ areas during the Apartheid era, were moved to Mitchells 
Plain and other similar suburbs.  This colour (racial) or ethnic divide has changed since 
1994, but the population of Mitchells Plain is still largely coloured27.  MPCHC services a 
larger area than just Mitchells Plain.  It also services Philippi, Brown’s Farm, Samora Michel 
and Crossroads, where the population consists predominantly of black African people27.  
This study was open to all people who access care at the MPCHC, so it is interesting to note 
that all participants classified themselves as coloured.  This could be as a result of the fact 
that most people accessing chronic medical care through MPCHC are from Mitchells Plain, 
rather than from the other areas which this clinic services.  There are primary healthcare 
facilities in Brown’s Farm, Philippi and Crossroads, which may handle chronic diseases for 
people living in those areas.  The researcher was unable to obtain records of the specific 
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details of where the inhabitants of these areas actually access healthcare, in relation to where 
they live.  Future research may aim to investigate this. 
 
Diagnosis Categories: 
The majority of the participants (37 of the 46) had only one diagnosis: cardiac failure, 
COPD, CVA, cancer, dementia, HIV or renal failure.  Some healthcare workers note, 
anecdotally, that people nearing the end of their lives, suffering from chronic illnesses, have 
many medical problems and are difficult to manage.  This is reported to be a barrier to 
providing palliative care75.  However, the data collected in this study suggest that, in a 
primary healthcare setting, most palliative care patients have only one diagnosis.  This is 
appropriate, because it could be suggested that patients with complex medical problems need 
to be managed at a secondary level, by a specialist physician.   
There was only one patient in the sample who had more than two diseases, and who thus 
may have benefited from treatment provided by a more specialised palliative care team, or 
by a physician, rather than a primary healthcare team.  As mentioned in the introduction, 
there was no such palliative care service at the time of this study, so this particular patient 
was cared for by the primary healthcare team. 
Eighteen of the 46 participants had some type of cancer and this shows that cancer is still a 
major burden of disease in our population.  This is validated in the prevalence study 
performed by Van Niekerk and Raubenheimer, which reported that 50.8% of palliative care 
patients admitted to hospitals in Cape Town, had been diagnosed with some form of 
cancer23. 
This study was open to patients who are HIV-positive and are in need of palliative care.  
However, only one HIV-positive patient participated in the study.  MPCHC does have a 
large and comprehensive Antiretroviral (ARV) clinic.  The fact that there were not more 
HIV-positive patients participating in this study is not necessarily indicative of low HIV 
prevalence in the community, nor does it necessarily suggest that there is no need for 
palliative care amongst HIV-positive patients in this community.  It may simply be related to 
the segregation of the ARV services.  There is an ARV clinic in the CHC, separate from the 
rest of the clinic, with a separate serving hatch at the pharmacy.  Each HIV-positive patient 
receiving treatment has a separate folder in the CHC, which is kept in the ARV clinic.  This 
segregation could possibly perpetuate the stigma of HIV infection.  It may be that the staff in 
the ARV clinic did not refer patients.  Saint Luke’s Hospice in Mitchells Plain offered an 
inpatient unit for HIV positive people, at the time of the study.  That service may have been 
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more readily utilised by the ARV clinic than this programme was, and the Saint Luke’s 
Hospice unit may have provided sufficient palliative care for the ARV clinic patients.   
 
Family Carers: 
Most patients who participated in this study had a family caregiver.  Only four patients did 
not want their family involved, or lived on their own.  One of the four who did not have a 
caregiver did live with his family, but, because his family did not want to be involved, he 
asked that they not be contacted.  Initially he did not consent to participating, because of his 
family.   He later came back and asked to join the programme, without the involvement of 
his family.  Perhaps, if the programme had been in place for a longer period of time, the 
palliative care team could have reached out to his family. 
Most family carers were female and they were, in general, younger than the mean age of the 
participants.  The biggest group of family carers consisted of spouses and then children of 
the ill participant.  This corresponds with the literature on carers36,76.  Burton et al. reported 
that, of the caregivers they had studied, 81% were female and 56.8% were spouses or 
partners of the patient36. 
Ninety-one percent of the patients who participated in this study had a family carer.  This 
indicated that there was a high prevalence of families that are caring for ill family members.  
Although, from these data, it may be concluded that patients were receiving care, there was 
no indication of the level of care they were receiving, nor was there an indication of whether 
or not the family was coping with caring for this patient.  More information is needed to 
determine whether or not the families in this community are able to take care of their own 
family members who are ill.  Future research could investigate this. 
 
Frequency of visits to healthcare facilities: 
When the objectives of this study were being formulated, it was hypothesised that, with a 
palliative care programme in place, there may be a significant difference in the number of 
visits made to the clinic or hospital by patients.  Given that no participants participated 
completely in the intervention, this hypothesis could not be tested through statistical 
analysis.  
However, the initial set of data collected was used to assess what happens when there is no 
palliative care programme in place.  Considering the set of data that was collected and 
presented in tables 3 to 6, one can appreciate the number of times participants did attend 
healthcare facilities with no programme in place.  If we take into account the attrition rate of 
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the participants in this study (43.9%), it is not surprising that the participants continued to 
visit the clinic and referral hospitals as they neared the end of their lives and became more 
severely ill.  The data indicate that, with no programme in place, a significant number of 
patients in need of palliative care visit the health care facility, outside of routine 
appointments. The fact that there is an increased number of patients admitted to hospital in 
the twelve months prior to dying from a chronic illness, is confirmed by the research 
published by DesRosiers et al19.   
Prior to the initiation of the programme which is the focus of this study, more than half 
(56.52%) of the participants had been admitted to hospital in the preceding six months.  This 
result is far lower than what DesRosiers et al, reported19.  DesRosiers et al, found that 97.9% 
of their control group had at least one hospital admission in the twelve months preceding 
their death19.  The time period of DesRoseirs et al.’s study (i.e. twelve months), is double the 
time period of this study19.  DesRosiers et al.’s study used a control group comprising of 
people who had died, from a chronic illness and who would have qualified for palliative 
care, at the hospital in the twelve months prior to the start of the intervention19.  This forms 
another bias for hospital admissions in the twelve months prior to their death, as the 
population from which they drew their sample, was that of hospital patients, their inclusion 
criteria was that of people who had died from a chronic illness, in hospital.    
Seven of the 46 participants had out-patient appointments at GSH, which is highly 
appropriate, when they have serious illnesses and GSH, although a tertiary hospital, acted as 
a secondary level hospital for MPCHC at this time.  Ideally, this kind of programme would 
have incorporated communication with GSH, as well as other healthcare facilities that 
patients may access care in, at the primary care level.  This communication would aim to 
provide continuity of care between facilities.  This communication was not set up, as it was 
intended that the programme would only run for a few months, so it was felt that networking 
may lead to false hope amongst the patients and staff; and would take more time and human 
resources to set up, than were available as part of this initiative.   
More than two-thirds of the participants had visited the emergency unit in the preceding six 
months.  Such visits imply urgent problems or deterioration in health that the patient and or 
family could not cope with.  This does not necessarily mean afterhours care, but un-booked 
visits to the clinic in which the patient was triaged as being moderately to severely ill. 
Although the mean number of visits was two, the maximum number of visits for one person 
was nine.  That is more than once a month, and this figure excludes their routine visits, 
which are scheduled to take place every three months.   
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As the participants in this study were clients at the CHC and accessed healthcare there, they 
would be expected to be visiting the CHC for routine medical care, so the fact that they all 
attended the facility at some point in the preceding six months is not surprising.  Some were 
quite ill and so could have been seen almost monthly, as is shown by the highest number of 
visits (five). Ideally, in palliative care, ill patients would be seen a few times a week77.  Some 
of the patients in this study may have been accessing palliative healthcare through St Luke’s 
Hospice or through the home-based care organisations, both of which worked in the 
community at the time of this study.  No attendance statistics were obtained to allow 
investigation of these possibilities.  Analysis of the data relating to the frequency with which 
patients accessed care at the CHC did not yield surprising results and merely helped to 
provide a clearer the picture of needs of the study participants.   
Analysis of the frequency of patient visits to the CHC or to GSH, after recruitment to the 
programme, indicates that they was a reduction in the frequency of visits per patient, with the 
maximum visits being 3 (to the emergency room at MP CHC).  This difference might be due 
to the time difference.  Prior to the recruitment to the programme, visits over a six-month 
period were considered.  After enrolment in the programme, consideration was given to 
visits from the time of recruitment until the end of the programme or until a patient died.  For 
some patients, this might have been the entire duration of the programme (six months), while 
for others the time period in question was considerably shorter.  It is possible that the 
intervention made a difference to the patients, resulting in the patient feeling more able to 
deal with their illness, the patient and family having realistic expectations with regard to 
their health and the family having more confidence in caring for their loved one.  However, 
this can only be surmised and no concrete statistically significant conclusions can be drawn, 
because Group B did not participate in the intervention.  It would have been more useful to 
report on frequency of visits rather than merely number of visits, in order to eliminate the 
problem of different periods of time for each participant. 
 
Comparison of Group A and Group B: 
The patients in Groups A and B were not statistically significantly different in gender, age 
range, diagnoses, presence (or absence) of a family carer, the relationship of the family carer 
(to the patient) and the gender of the family carer (p > 0.05 in each case).  However, the 
major difference in the demographics was between the attrition rates.  In Group B, 66.67% 
of the patients died during the study, compared to only 20.00% in Group A.  This difference 
is statistically significant (p < 0.05).  This could imply that the participants recruited to 
Group B were possibly more ill than those in Group A and closer to the end of their life.  The 
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reason for this could be a difference in referral patterns in the second half of the programme, 
which may have led to referral of people who were more ill.  It is easier to deem patients to 
be in need of palliative care when they are very near the end of their life.  It is more difficult 
when they may be in need of palliative care, but still have a few months to live.38,39,78,79   
No assessment was made of the participants’ abilities to perform activities associated with 
daily living, which could have served as an indication of how ill patients were.  This could 
have been done using an instrument such as the Karnofsky performance status scale80.  In 
retrospect, it cannot be determined whether or not there was a statistically significant 
difference between the two groups, as far as the severity of illness of the patients was 
concerned, during the respective periods of recruitment.  This is a limitation of the study and 
could be incorporated into future studies of this nature. 
It is important to note that the primary researcher in this study was present in the clinic, 
working as a doctor in the clinic, for the first two-and-a-half months of the programme.  The 
doctor left the clinic at the beginning of the recruitment for Group B, because she was 
deployed to another clinic.  This may have had an impact on the differences between the two 
groups of patients.  For example, the absence of the researcher meant that there was no 
clinician to remind colleagues to refer patients to the programme and the researcher was not 
on hand to answer questions relating to the suitability of prospective patients for referral to 
the programme. 
Very few participants (three) in Group B saw the doctor as part of the programme.  This 
would have meant an extra visit to the clinic, soon after being recruited to the programme.  
They had seen a clinician on the day they were referred to the programme and would have 
been given a routine follow up appointment in the six months which followed.  After 
recruitment, they were asked if they would like to see a doctor again, in the next few weeks, 
to explain more of the details of their illness and their prognosis.  They did not want to come 
back to see the doctor so soon.  Some stated that they would be happy to see this doctor at 
their next appointment, between one and three months later, but not before that.  For some 
participants, it would have been difficult to get transport back to the clinic so soon after the 
visit at which they were referred to the programme.   
As stated above, it was only at the consultation with the doctor, as part of the intervention, 
that we explained to them that their chronic illness had become life threatening.  In the other 
palliative care programmes in Cape Town (viz., Abundant Life and St Luke’s Hospice), 
patients are happy to meet with a clinician to optimise their care, when they understand what 
their prognosis is, prior to joining the programme.  If this study had been structured 
differently, with patients being informed, from the outset, that they were now in need of 
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palliative care and were near the end of their life, then the responses from the patients, with 
regard to the intervention, may have been significantly different.  This procedure was not 
followed, given that the researcher was attempting to obtain an accurate indication of the 
baseline level of patient-reported outcomes before patients had joined a palliative care 
programme.  It was decided that the referring clinicians should continue their normal 
consultation and identify patients suitable for referral, but not take responsibility for 
informing the patients that they were terminally ill and in need of palliative care.  The 
researcher did not want to increase the workload of the clinicians by asking them to “break 
the bad news” of the patients’ poor prognoses.  It was felt that the procedure adopted in this 
study may result in greater numbers of patients being referred to the programme by the 
clinicians.  It should be noted that it is good clinical practise, as a medical doctor, to inform a 
person of their prognosis and what their future holds for them81.  However, this is not 
necessarily a medical doctor’s routine practice and the researcher did not want to interfere 
with the referring clinicians’ consultations, while attempting to obtain information on the 
current care of terminally ill patients in the CHC, prior to an intervention.  The researcher 
did not advise medical doctors to change their approach, if it was already routine practice for 
them to advise a patient on their poor prognosis and assist them to plan for the future.  If 
clinicians, who were not in the habit of informing terminally ill patients of their prognosis, 
had been asked to “break the bad news” to the patients, this may have been a barrier, 
inhibiting referral to the programme.  It is worth noting that most clinicians (except the 
researcher and the Family Physician in the clinic) did not know any criteria for initiating 
palliative care and readily acknowledged that they did not know when to start palliative care, 
nor how to initiate it.  In South Africa, it has only been in recent years that the theory 
underlying palliative care has been taught in medical schools as part of undergraduate 
curricula16.  Thus many doctors and nurses currently administering healthcare in South 
Africa were not exposed to palliative care per se, during their training and they do not know 
how to change from providing preventative and curative care to providing palliative care.  
Therefore, this transition tends to be abrupt and ends up becoming a case of “breaking bad 
news” compared to a gradual introduction of information and preparation that a patient’s 
chronic disease could cause their life to be shortened significantly.  The act of “breaking the 
bad news” often becomes a barrier, with healthcare professional avoiding the issue and thus 
preventing or delaying the implementation of good palliative care timeously75.  “Breaking 







A comparison of the number of deaths amongst the patients assigned to each of the two 
study groups revealed that Group B experienced a higher attrition rate during the first half of 
the period following the initiation of the recruitment process, compared to the equivalent 
period for Group A.   This suggests that the Group B participants, as a whole, were more 
severely ill at the time they were referred to the programme.  As a group, the patients 
assigned to group A appear to have be referred earlier in their respective disease trajectories.  
Part of the rationale of palliative care is to prepare patients for death and offer support to 
them as they near the end of their lives.  The effectiveness of such interventions is limited if 
they are initiated when patients are too close to the end of their lives.  In the context of this 
study, this issue may have had an impact on participants and their families not wanting to 
come to another doctors’ appointment or attend meetings of the support group.  If patients 
knew they were dying, then making extra visits to the CHC might have seemed pointless.  
And if patients did not know that they were dying, they would not have understood the need 
for assistance and support in their last few weeks of life.  
It is not clear to what extend the clinicians may have had trouble identifying patients in need 
of palliative care.  This question was not asked of the clinicians, directly.  It could be 
surmised that the clinicians became better at identifying people closer to the end of their life, 
as the programme progressed.  This could be surmised by the lack of patients dying early in 
group A and could explain the difference in attrition between the two groups.  This difficulty 
clinicians experience, is reported in the literature and models have been formulated to 
attempt to address this problem50.  More could have been done to address this potential 
problem and assist clinicians in identifying patients earlier in their disease progression. 
In palliative care research it is expected that there will be a certain attrition rate, as the 
participants are all nearing the end of their life82.  Attrition rates vary between studies and 
cannot easily be predicted.  For example, Francis et al. reported an attrition rate of 32%, over 
an eight-month period in patients with Karposi Sarcoma71 and Temel et al. reported a 70% 
attrition rate, over a twelve-month period, in patients with metastatic small cell lung cancer53.   
 
Visit to the doctor: 
Approximately two-thirds (70%) of Group A participants attended a consultation with a 
doctor after the collection of their APCA African POS data.  The fact that such a significant 
number of the patients took advantage of this opportunity may be due to the fact that their 
interest in this programme was piqued by the APCA African POS.  This response from 
Group A patients may also have stemmed from the fact that they had established a 
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relationship with the coordinator over the 6 weeks of data collection.  Alternatively, the fact 
that they were given more notice about seeing the doctor and could make the necessary 
arrangements, may have led to this positive response.   
By comparison, only three (14.29%) of the Group B participants attended the doctor’s 
consultation.  Another four attended a consultation at the end of the study.  Unfortunately no 
APCA African POS results were collected from these four participants, after their visit to the 
doctor.   
 
Comparison of APCA African POS results between Group A and Group B: 
Comparison of the APCA African POS data sets for the two groups of patients shows that 
the patients in Group B reported experience more pain overall compared to those in Group 
A.  Given that more than half of Group B participants then died within the three weeks 
which followed the collection of the data, this difference may be understandable and to be 
expected.  With regard to the responses on symptoms, the difference between the two groups 
was statistically significant.  Patients in Group B reported more symptoms than patients in 
Group A.  Again this trend may be linked to the fact that more than half of Group B then 
died within the three weeks which followed the collection of the data.  As a person nears the 
end of their life it is to be expected that their health will deteriorate and they may exhibit 
more symptoms of disease.  Considering the question on feelings of worth, there was a 
significant reduction in feelings of worth for those who were sicker and nearer to the end of 
their lives.  The last question for which the data showed significant difference between the 
two groups related to confidence.  The question asked of the family was, “How confident 
does the family feel in caring for [the patient]?”.  The data collected indicate a significant 
difference in the confidence levels of the families, in caring for their loved ones.  The 
families caring for a person who was more severely ill were was less confident.  This result 
may be expected from people who have little medical experience, as in the case of families 
who are caring for loved ones who are dying.  This emphasises the importance of home-
based care organisations and home visits by an experience healthcare worker, to equip the 
family to cope, as well as offering practical assistance and emotional support to the family, 
especially in the final weeks of a loved one’s life.  The data showed that the differences in 






Comparison between participants who died during the study and those that did not: 
Statistical analysis of the initial APCA African POS results (i.e. the data captured at the 
outset) for each group of patients showed that there were significant differences between the 
responses reported by those patients who died during the study and those who survived the 
study.  Therefore the APCA African POS results were divided into two groups, based on 
whether they belonged to a patient who had died or a patient who had survived, and 
subsequently analysed in more detail. 
Comparison of the set of data collected from those patient who later died (during the study) 
with the set of data collected from those who survived, indicated that there were significant 
differences between the responses relating to “pain”, “worry”, “worth” and “information”.  
This differs from the comparison between Group A and Group B at week zero, where the 
results relating to “pain”, “symptoms”, “worth” and “confidence” were statistically 
significantly different.  These results suggest that “pain” and “worth” warrant serious 
consideration in palliative care, as these are areas that are highlighted as problem areas for 
people who are nearing the end of their life.  Considering all the questions that were asked of 
the patients, it may be surprising that there was not a significant difference in the responses 
to more of the questions from people who are very ill, compared to those who were not as 
severely ill.  This issue may be worth considering in more detail future studies.  
Analysis of the number of patients who died before and after three completed weeks of 
involvement in the study, showed that there were statistically significant differences (p < 
0.05), but when the APCA African POS results for the two groups were compared, there was 
only one question for which the responses were statistically significant different.  The 
question of interest relates to “information”, where the family carer was asked if the family 
received enough information about the patient’s illness.  One reason for the lack of 
significant differences in the responses to the other questions could be the small number of 
responses that were analysed, as the groups were so small.  The number of patients that died 
before three completed weeks is 13 and after three completed weeks are five, this number are 
too small to analyse appropriately.  It is difficult to get statistically significant differences if 
sample size is too small74.  The difference in the responses to the question on “information” 
may have been due to the fact that the family member answering the APCA African POS 
questions was not present when the patient was told that they had a life-threatening illness.  
However, it is unlikely that this was an issue.  Only three participants had more APCA 
African POS questions asked of them after their visit to the doctor.  It should be noted that 
the consultation with the doctor was meant to be in the format of a family conference, though 
there were no data on exactly who was present for the doctor’s consultation.  It has already 
been stated that, where chronic diseases are concerned, it is difficult to predict the trajectory 
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and end point.  So whether a person is going to die in the next three weeks or the next six 
weeks, the response could still be the same as those for a patient who is likely to die in the 
next few months.  This is evident in the results, as there are few responses that are 
statistically significantly different for those patient who were closer to dying than those who 
were not.   
 
Comparison of APCA African POS between different diagnoses: 
In comparing the responses to questions on the APCA African POS, across disease 
categories, the only statistical significant difference was for the question on “symptoms” 
and, within that question, the difference was between the group of patients with cancer and 
the group of patients with multiple co-morbidities.  The results show that cancer patients 
reported more severe symptoms than patients with multiple co-morbidities, which included 
patients with cancer.  Amongst the patients with multiple co-morbidities, it was not 
determined which disease was their biggest concern or debilitating factor.    This confirms 
what we already know, that cancer has a high symptom burden and patients with cancer are 
particularly in need of palliative care. 
 
Cross section time regression analysis of whole cohort: 
The entire cohort of patients was analysed together, with cross section time regression 
analysis, as very few participants had taken part in the intervention by attending the doctor’s 
consultation and the meetings of the support group, during the collection of the APCA 
African POS.  This analysis provided an indication of the patient-reported outcomes within 
MPCHC, with no palliative care programme in place.  The data provide a good indication of 
the burden of disease within palliative care.  The rationale for having a control group (Group 
A) was to compare the impact of the research assistant and weekly contact on participants, 
with the intervention, which entailed a support group and an in-depth consultation with the 
doctor.  However, as there were only three patients from Group B who took part in any part 
of the intervention, the comparison was not possible. 
There was no significant change over time with regard to the responses to the questions on 
“pain”, “sharing”, “worth”, “peace”, “planning”, “information”, “confidence” and “worry”.  
During the collection of the APCA African POS, only the three participants who attended the 
doctor’s consultation would have been told that their chronic illness was no longer curable 
and that they were now dealing with a life-threatening illness.  The bulk of the cohort did not 
know for certain that their disease was no longer curable and that it was now life-threatening, 
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though it may be assumed that they were aware that this could be the case.  Being able to 
share thoughts with their families,  feeling their life was worthwhile, having peace and 
planning for the future, are related to knowing they were dealing with a life-threatening 
illness.  These aspects may have changed had they been told that they were in fact dealing 
with a life threatening illness.   
The responses to the questions asked of the families showed no statistical significance with 
regard to “information about the patient”, “confidence in caring for the patient” nor “worry 
over the patient”.  Although there was no difference over time in the response to the question 
on “confidence”, overall the data suggest that families had confidence in caring for their 
dying loved one from the beginning and that did not change.  This is a positive attribute for 
this community: they have confidence in caring for ill people.  This may be because they 
accept and embrace death and dying are a part of their lives. 
The responses to the question on “symptoms” did show a significant difference (p < 0.05).  
The burden of symptoms changed over time.  Initially there was an increase in the score 
attributed to symptoms, from week zero to week one, then the reported scores dropped again 
in week two, and increased once again in week 6.  This could be related to the patients’ 
initial realisation that there was something wrong with them and more reporting of 
symptoms, before returning to a lower score. The responses to the question on “worry” 
showed a significant difference in reported scores with the passing of time (p < 0.05).  The 
patients became more worried as time progressed, with no palliative care programme in 
place.  Defilippi and Cameron showed that with better palliative care in place, patient’s 
worry was reduced64.  It is possible that the fact that we are asking these questions may have 
alerted patients to the fact that there was a problem and this increased their worry. 
When conducting research, there is a possibility that the presence of a research assistant and 
the process of answering questions from a scale or tool would have an impact on the 
outcomes reported by patients who were not involved in an intervention.  However, the 
APCA African POS has been validated for this problem and found to have a very low impact 
on changing the participant’s reported outcomes.  When initiating this study, the aim was to 
implement a programme for people facing the end of their life and evaluate the impact of 
that programme.  A control group was needed to compare the impact of answering the 
APCA African POS questions and the presence of the research assistant, to the intervention, 
which included a support group and an in-depth consultation with a doctor.  The results for 
the cross section time dependent regression analysis in this study, for the whole cohort 
support the validation of the APCA African POS, indicating that there is little change over 




Cross section time regression analysis participants who attended the doctor’s 
consultation: 
The APCA African POS responses of the three participants who attended the doctors’ 
consultation were analysed at week zero and in the week after the doctor’s visit.  Although 
there were only 3 participants to analyse and this is a very poor sample size, the researcher 
felt it was important to report the findings.  The only statistically significant response was 
the change in the scores for the question on “worry” (p < 0.001).  The results of the analysis 
implied that, after the consultation, the level of “worry” reported by the patients increased.  
The philosophy of palliative care does advocate merely a single consultation with the doctor, 
but rather continuity of care.  So, after one visit to the doctor, the participant may have felt 
more worried about the future, but with ongoing support, this worry by reasonably be 
expected to improve.  This data collected during this study does not allow this issue to be 
investigated in any detail.  An attempt to provide better continuity of care could form the 
basis for promoting the establishment of and support a programme that would run for much 
longer than six months.  Although the responses to the question on “worry” were the only 
statistically significant responses, Figure 4 shows the range of scores graphically and there 
are differences in almost all questions.  But given the sample size (n = 3), statistical analysis 
is effectively meaningless. 
Defilippi and Cameron published a study, which aimed at supporting home-based carers 
(HBC) and providing ongoing training of the HBC, with the aim of improving patient 
outcomes64.  They used the APCA African POS to evaluate the patients’ responses to the 
improved training of the carers.  The difference in their study, compared to this study, was 
that, each time the APCA African POS was applied, it coincided with a home visit from the 
HBC and interaction with her/him.  Their results showed that, over a period of six visits from 
the HBC, there was improvement in the responses to all ten questions.  The responses to the 
questions on “symptoms” reduced gradually and the responses to all other questions 
increased, all showing an improvement with each visit.  In the study which is the focus of 
this research report, the patient only saw the clinician once, not six times.  The results 
reported by Defilippi and Cameron suggest that, with continued care, patient-reported 
outcomes may improve.64 
There was no clinical assessment of how ill a person was at any point in this programme.  
That was not included in the protocol, but could have been helpful in allowing deeper 
analysis of the data collected from patients.  This data could have been used to determine the 
correlation between the clinical assessment of the patient and the responses to the APCA 
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African POS questions relating to “symptoms” and “pain”.  Knowing if a person is bed 
bound or able to complete their personal activities of daily living, might have been helpful.  
This is an oversight in this study and could have been incorporated by the research assistant 
with each collection of APCA African POS data. 
It has been mentioned that the primary researcher was present at the clinic, working as a 
doctor, for the first two and a half months of the programme.  During this time it was noted 
that staff were reminded about the programme when they saw the researcher and 
remembered patients that they needed to refer.  It is unclear whether the subsequent 
departure of the researcher and her absence during the remainder of the programme had an 
impact on referral to the programme.  It is suspected that the lack of daily reminders to 
clinicians and constant encouragement to refer patients to the programme early in their 
disease trajectories could have impacted on referrals.  
Limitations of the study: 
As discussed above, many of the participants in Group B, the intervention group, were more 
severely ill and died sooner after recruitment than participants in Group A.  There were some 
factors that seemed to limit the recruitment to this study and have implications on the 
outcome of this study.  The first limitation is that referrals to the study were not consistent 
throughout the duration of the study.   The researcher believes the participants who were 
referred later in the programme were more severely ill, impacting on the attrition rate and 
thus outcomes of the study.  It is possible that the clinicians had difficulty in identifying 
patients to refer to the programme and required more assistance in this initial process of 
identification of participants.  The attrition rate in group B may point to the clinicians 
becoming better at identifying patients in need of palliative care, but at a later stage in their 
illness.  
There was no objective marker of how ill a person was, at any point in the programme.  In 
hindsight, it could have been simple enough to add, into the data collection protocol, a 
performance score, to assist with assessing the severity of each person’s illness at strategic 
points in the study.  This limits the conclusions that can be drawn about the degree of illness 
in the study group.   
When comparing admissions to hospital or visits to the CHC prior and after the intervention, 
it would have been more useful to report the frequency of visits (i.e. number of visits per 
period of time).  This analysis of frequency would have made the results of this study, with 
regard to hospital admissions or CHC visits, easier to compare to other studies.    
The procedure adopted for this study stipulated that participants were not informed by the 
clinicians that their chronic illness was now life threatening and they were deemed in need of 
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palliative care.  By not informing patients of these facts in the beginning, they did not know 
the full extent of what was wrong with them and so did not participate in the interventions 
offered to them.  This limited the conclusions that could be drawn from the data. 
There was little information on what happened in the doctors’ consultation.  It is not clear 
what was discussed and who was present for the consultation.  The responses that the family 
members of the participants gave for some of the APCA African POS questions could have 
been affected by the consultation with the doctor.  This lack of information limits the 
conclusions we can draw about the responses of the family in the APCA African POS 
questions.   
The most significant limitation in this study is that participants recruited to Group B did not 
take up the offer of an extra visit to one of the doctors in the clinic and, one reason for this, 
may have been that they had just been to a clinician on the day of recruitment and could not, 
or were not, willing to get back to the clinic to see a doctor again too soon.  This is one of the 
reasons given by respondents for not wanting to meet with a clinician, as part of the 
intervention.  This obstacle was not anticipated during the planning phase of this study and 
actually had a major impact on the study.  Without the doctor’s consultation, participants 
could not be invited to join the support group and so very few participants in Group B took 
part in any part of the intervention.  This could be remedied with a study over a longer time 
period, by modifying the study to include the initial consultation as part of the recruitment 
and consent process, and by having stricter inclusion and exclusion criteria for the 
intervention group, such that involvement in the intervention is mandatory. 
If this type of programme were a permanent service at a primary health care facility, there 
would be a need to communicate with other levels of health care facilities which patients at 
primary care access.  This would enable clear communication between health care providers 
at all levels of care, from home based care organisations up to secondary and tertiary health 
care facilities.  This research study did not create this communication channel, as the 
researchers was felt that it would take time to create and would lead to false hope, as the 
study was only planned to run for six months.  This created a limitation with regard to how 
successful such a programme could be for the health system, as a whole.  
These are the limitations of this study.  Ideas of how to avoid these limitations in future 






Participants Evaluation of the programme: 
In our public health system, community health centres are one-stop shops for patients, seeing 
a clinician, getting procedures done (including routine blood tests and other primary health 
care procedures, such as pap smears), seeing an Occupational Therapist, Physiotherapist or 
Dietician.  There is also a Social Worker available daily and a Psychiatrist available weekly.  
However, there is little help in the busy MPCHC, from when a person walks through the 
door, to when they leave.  There is an expectation that the person will know where they have 
to go at each point in the process of accessing care.  Nobody guides them and “shows them 
the way”.   Unfortunately, if they are brave enough to ask for help or guidance, it is often 
given in a curt manner by medical staff.   
They are very likely to see a different person for each aspect of their care, each time they 
make a visit to the clinic.  For a person with a chronic illness, and especially those in need of 
palliative care, continuity of care is vital81.  For health education and motivational 
interviewing, building and maintaining rapport with the patient is essential for success, if 
there is to be an improvement in a patient’s perception of his/her illness.  If a patient sees a 
new clinician at each visit, he/she may always have the same health promotion discussion, 
being advised, for example, to stop smoking, and he/she never hear that their diet should 
change in addition to this.  In palliative care, continuity of care means building a relationship 
of trust with a healthcare worker, which may result in improvement in the patient’s 
symptoms, and allow the patient and his/her family to have questions, which may arise from 
previous discussions, answered satisfactorily.  It is difficult to have such questions answered 
satisfactorily, if the clinician is new and was not present in the previous discussion, from 
whence the questions arose.  Continuity of care also means that a patient does not need to 
repeat the story of their disease at each visit.  It also prevents a patient from having to 
repeatedly acknowledge to a stranger that they know they are dying.  Continuity of care is an 
essential element of good palliative care and as it cannot be assured in a CHC, especially in 
MPCHC, the idea of a palliative care coordinator, who could provide that continuity of care 
and assist in accessing care, was crucial in the role of the coordinator created for this project.    
The coordinator was able to provide the guidance needed by patients in order to navigate the 
healthcare system in the CHC, assessing care when it was needed and providing continuity 
of care for participants.  The coordinator was able to listen to the participants, when she had 
time.  This act of listening, in a busy clinic where few staff are able to give too much time to 
an individual patient, was an important part of her work.  All people need to be validated as 
being important and none more so than a person who is dying and possibly feeling that their 
life is no longer worthwhile.  Listening attentively is an important element of caring and 
making a person feel that they are important. 
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Ninety-five percent of the participants who answered the evaluation stated that the co-
ordinator was helpful.  She listened to them, guided the participants through the clinic and 
made their clinic visits easier.  She organised help for them, when they needed it and, on a 
practical level, she even got their folders out for them.  All respondents wanted her role at 
the clinic to be continued.   
It cannot be ascertained to what degree the coordinator, with her unique set of personality 
traits, influenced people’s perceptions of the study.  It is unclear what criteria a suitable 
candidate for this role would need to meet.  The coordinator was empathetic and understood 
that just listening to a person can bring about improvement in the general wellbeing of that 
person.  The coordinator had been trained as a hospice volunteer and had a number of years 
of experience working in St Luke’s Hospice as a volunteer, visiting and caring for Hospice 
patients in Mitchells Plain.  She knew all the participants’ names and was always happy to 
see them.  She got to know the staff at the CHC and gently enquired about how much she 
could in fact help a patient.  She found ways to get folders out, so that a person did not need 
to get to the clinic at 05H00 and stand in a queue for more than an hour.  She found ways to 
get medication from the pharmacy with minimal waiting, but without seeking special 
treatment for a select group of people.  At times she would sit with a person, to keep them 
company, while they waited to be seen, not pushing them to the front of the queue, but 
helping them pass the time.  This role was seen as highly beneficial, by the participants.  
They were unanimous in wanting her to continue.     
Evaluation of the visit to the doctor showed the responses to be more positive than negative, 
with room for improvement.  It would be beneficial if there was some continuity of care with 
the same doctor, as stated above, which may impact on this evaluation.  The consultation 
they had could have been the only time they met with this doctor (before or after this 
consultation).    
The support group was an integral aspect of the intervention within this programme.  
However, as shown in the results of the study, only members of Group A attended the 
meetings of the support group, after collection of their APCA African POS data.  Group B 
participants were only invited to the support group, once they had seen the doctor and it was 
explained to them that they were in need of palliative care.  Only three participants in Group 
B attended the doctor’s consultation and none of them attended at least one meeting of the 
support group.  As Group A participants had completed their APCA African POS data 
collection before attending the meetings of the support group, this evaluation is the only 
source of feedback we have regarding the benefits of the support group. 
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Support groups offer a different space for patients and family members to meet other people 
with similar problems and share their experiences.  Where psychological support is 
concerned, it is often a person who is going through, or has gone through, what one is going 
through, that offers the most valuable help and support.  It was a place for health education, 
specific for palliative care, to be given, and a place where ideas could be shared. 
Although not all respondents had attended a meeting of the support group, all of them 
wanted it to continue.  With regard to the specifics of the meetings of the support group, 
respondents stated that they wanted them organised monthly at the clinic, in the same venue 
that had been used during the study.  The reasons that participants cited for continuing to 
attend meetings of the support group included meeting with similar people with similar 
problems and being able to support each other, as well as receiving input from guest 
speakers.  These were the highlights of the support group.  The guest speakers included a 
palliative care specialist physician, who discussed pain management, a palliative care 
specialist nursing sister, who talked about practical tips on nursing a terminally ill family 
member and a palliative care expert spiritual counsellor, who discussed total pain and 
spiritual pain. 
Overall the respondents wanted the whole programme to continue with no changes. 
 
Staff evaluation of the programme: 
There was a good representation of all clinical staff in the survey.  Most staff members who 
completed the evaluated form knew about the research programme and most were involved 
with referring patients to the programme.  There were some staff who did not know which 
patients needed to be referred to the programme and this suggests that on-going training and 
information may have been needed throughout the programme.  One of the responses about 
time in trauma: “Working in trauma there is little time for interaction with the [patients]”, is 
exactly why the programme should be used, to potentially reduce the time spent with each 
patient by busy clinicians.  Approximately one-third of the staff who completed the 
evaluation indicated that they had asked the programme coordinator to do other things 
besides her job.  This indicates that she was an asset to the clinic, beyond simply running the 
palliative care programme. 
The responses stated that, for more than two-thirds of staff, the programme had a moderate 
to large impact on them.  The comments reviewed in the results chapter indicate the reasons 
why the programme had an impact.  There was an overwhelming response that the 
programme should continue.  Many medical staff indicated that they would like to be more 
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involved in the programme.  There was a positive response to wanting more information and 
wanting palliative care training. 
There were limitations in the design of this study which, if anticipated, could have been 
resolved.  This may have led to more effective research and greater insights may have been 
gained.  Consideration of the recommendations, which have been made, may allow 
researchers undertaking similar studies in the future to streamline their investigations.  
Despite the attrition rate experience in this study, and the low level of involvement in the 
intervention initiative, the programme was reported as beneficial to both participants and 
























CHAPTER 6: CONCLUSION AND RECOMMENDATIONS 
The aim of this study was to evaluate the patient reported outcomes in Mitchells Plain 
Community Health Centre prior to an intervention and then to evaluate the impact of the 
intervention, involving a support group and focused care, for people facing life threatening 
illnesses.  The aim was partially met.  We were able to evaluate patient reported outcomes 
prior to an intervention.  Unfortunately, due to the high attrition rate in the intervention 
group, we were unable to evaluate the impact of the intervention by the same method; that of 
patient reported outcomes.   
The intervention was evaluated by means of patient and staff evaluation forms.  The results 
of the evaluation showed that the patients and family carers found the programme very 
helpful and unanimously wanted the programme to continue with few changes.  The staff 
evaluation also found the programme very helpful and wanted the programme to continue.  
There were good points that came out of the staff evaluation that could be useful in running a 
programme like this in future.  The staff wanted more training around palliative care and 
more involvement in the programme.  The lack of involvement from the clinic staff was 
structured purposefully, so that the programme was less burdensome on staff who are 
already overworked.  However, they should still feel welcome to participate in all 
programmes in the clinic, if their work allows them to.  By including staff in the programme, 
it would become an integrated part of the clinic, not an isolated programme within the clinic. 
The first objective, to determine the prevalence of people with palliative care needs at 
MPCHC, was not met.  Relying on the clinicians to correctly identify all people accessing 
care at MPCHC who were in need of palliative care and who qualified for palliative care 
according to the inclusion criteria was not a reliable method of identifying these patients.  A 
more in depth prevalence study is required to meet the first objective. 
Some of the objectives set out were met.  This study was able to assess the physical, 
psychological and spiritual concerns of people facing life-threatening illnesses, prior to an 
intervention, and the extent to which they get admitted to hospital or seek urgent medical 
attention, prior to an intervention.  The patient report outcomes identified that, in MPCHC, 
pain management and assisting patients in their feelings of worth need be addressed to aid 
them in their physical and psychological well-being.  The responses from the family carer 
show that there is a good baseline level of confidence in caring for their ill family member.  
This is a positive protective factor for this community and should be encouraged and 
nurtured in future work in this community. 
The objectives of determining whether or not there is a change in patient reported outcomes 
or hospital admissions with a programme in place could not be met.  This failure to meet 
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these two objectives was due to the attrition rate and lack of participation in the intervention 
by the intervention group, Group B. 
 
Recommendations: 
1) A permanent palliative care programme, based at primary health care facilities, run 
by a lay person, in contact with a clinician.  Providing holistic palliative care and 
support to patients, families and staff involved with palliative care.    
2) If a permanent programme is not realistic at present, a study over a longer period of 
time is recommended.  This would allow for time for participants to attend a doctor’s 
consultation, for continuity of care with that doctor and for full participation in the 
intervention. 
3) Continuous reminders about criteria for referral to enable people to be referred to the 
programme (or study) earlier in their disease progression so that the benefit is not 
only offered within weeks of their death.   
4) A support group held monthly, in a central venue, as suggested by the participants.   
5) Palliative care training for the staff at the CHC.  The evaluation of the staff showed 
that they wanted more training and the results from the patient’s consultation with the 
doctor show that there is room to improve the palliative care that is currently 
practised in the CHC. 
6) Opportunities for CHC staff to be more involved in the programme, thus integrating 
it more into the daily running of the CHC.  
 
It would be ideal if a programme like this could be set up permanently and evaluated for 
impact of the programme.  The benefits of this would be a longer time to establish the 
programme, with more participants and a more extensive programme that networks with 
referral hospitals and community based organisations involved in palliative care.  A 
permanent programme would allow for continuity of care for participants.  In the 
participant’s evaluation of the doctors’ visit, the lack of continuity of care can be seen.  The 
analysis of the participants in Group B that did visit the doctor showed increase in worry 
over time.  In only one consultation it is not possible to give information and allay all fears, 
not giving time for the patient and family time to think about what has been said and to 
return with questions.  This can only happen over a period of time, which was not available 
in this study.  Over a longer period of time it is hypothesised that a programme like this can 
reduce hospital admissions and length of hospital stay, as the Abundant Life programme has 
demonstrated19.   
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If it is not possible to have a permanent programme, a study over a longer period of time 
would be better to enable the points above to take place.  “Breaking bad news” to 
participants and assisting them with their illness at recruitment to the programme, would be 
better.  The initial APCA African POS can be used as the control, compared to having a 
control group. 
Through personal communication with one of the members of APCA who has been involved 
with the development of the APCA African POS, it seems that the research tool does not 
need to be administered weekly for six weeks (J. Downing, personal communication, 19 
September, 2013).  Rather, it can be administered four times, with an equal time interval 
between collection dates.  That time period could be a month, a fortnight, a week or less, 
depending on what is suitable or most convenient for the study at hand and the patient 
concerned.  
Palliative care training for all clinical staff would be beneficial.  Initially it was offered to the 
clinic, but due to other circumstances it was not taken advantage of.  If all staff were trained, 
with improved skills and knowledge, then identifying patients in need of palliative care 
would be easier for them and “breaking the bad news” would also be less daunting.  The 
training that was offered can still be provided, in discussion with HPCA, if MP CHC staff 
are still interested in more training.     
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Abundant Life Program 
Support for people with chronic illnesses 
 
Would you be surprised if your patient were to die in the next 6 months – 1 year? 
 
Does your patient have: 
Congestive Heart Failure  1. Symptoms despite maximal medical therapy? 
     2. More than 5 admissions in the past 6 months? 
     3. Associated organ failure? 
 
Chronic obstructive airway disease  1. Disabling SOB at rest? 
     2. More than 5 admissions in the last 6 months? 
     3. Associated Cardiac Failure? 
 
Renal Failure    1. End stage renal failure (GRF <15)? 
     2. Unsuitable/rejected for dialysis? 
 
Stroke     1. Severely disabling 
     2. Severe dysphagia 
     3. Recurrent infections and sepsis  
 
Cancer     Terminal Cancer 
 
Misc     1. Patient in need of surgery, not medially fit 
     2. Severely bedridden 
     3. Sever bedsores 
 4. Does the patient require significant assistance  















Appendix B:                                                                                                           
Demographic Details: 
Patient Study Identification number: __________________  
Date of Birth: __________________   Sex:      
Ethnicity:      
Diagnosis:      
    specific cancer: ____________  
    
    Multiple co-  
Care Giver:  
Date of Birth: __________________   Sex:   M    
Ethnicity:      
Relationship to patient:      
   
   
Recent admissions to hospital:  
Have you had any admissions to a hospital in the     yes/no  
last six months?  If yes, which hospitals? ___________________________________  
And how many visits ?: ___________________________________  
Have you had any visits to outpatient clinics at another     yes/no  
Government health care facility in the last six months?  
If yes, which clinic? ___________________________________________________  
Have you had any emergency visits to MPCHC Trauma     yes/no  
unit in the last 6 months?  If yes, how many? ________________________________  
Have you had any visits to other doctors or clinics other     yes/no  
than MPCHC?   If yes, how many? _______________________________________  
And where did you access them?____________________________  
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Appendix C:  
APCA African POS 
Patient Study Identification number:____________________________ 
 
ASK THE PATIENT POSSIBLE RESPONSES 
Q1. Please rate your pain (from 0 = no pain 
to 5 = worst/overwhelming pain) during the 
last 3 days. 
0 (no pain) - 5 (worst/overwhelming pain) 
0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
Q2. Have any other symptoms (e.g. nausea, 
coughing or constipation) been affecting 
how you feel in the last 3 days? 
0 (not at all) - 5 (overwhelmingly) 
0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
Q3. Have you been feeling worried about 
your illness in the past 3 days? 
0 (not at all) - 5 (overwhelmingly) 
0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
Q4. Over the past 3 days, have you been able 
to share how you are feeling with your 
family or friends? 
0 (not at all) - 5 (yes, I’ve talked freely) 
0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
Q5. Over the past 3 days have you felt that 
life was worthwhile? 
0 (no, not at all) - 5 (Yes, all the time) 
0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
Q6. Over the past 3 days, have you felt at 
peace? 
0 (no, not at all) - 5 (Yes, all the time) 
0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
Q7. Have you had enough help and advice 
for your family to plan for the future? 
0 (not at all) - 5 (as much as wanted) 
0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
ASK THE FAMILY CARER  
Q8. How much information have you and 
your family been given? 
0 (none) - 5 (as much as wanted) 
0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
Q9. How confident does the family feel 
caring for ____? 
0 (not at all) - 5 (very confident) 
0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
Q10. Has the family been feeling worried 
about the Client over the last 3 days? 
0 (not at all) - 5 (severe worry) 
0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
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Appendix D:  
Abundant Life Programme Evaluation 
Participants 
Please tick the appropriate block, or the block that best answers how you feel. 
Patient      Care Giver/Family 
Evaluation of the co-ordinator position: 
Has the presence of the co-ordinator in the clinic had an impact on your experience of the 
clinic? 
No help at all Not really Some help Helpful Very helpful 
     
 
In what ways has she assisted you? 
Listened to you    Not really Sometimes  Yes 
Took an interest in your life  Not really Sometimes  Yes 
Understood you    Not really Sometimes  Yes 
Tried to help solve your problems Not really Sometimes  Yes 
Made your visit to the clinic easier Not really Sometimes  Yes 
Guided you through the clinic  Not really Sometimes  Yes 
Answered your questions  Not really Sometimes  Yes 
 Got you help when you needed it Not really Sometimes  Yes 
Got you help when you didn’t know you needed it 
     Not really Sometimes  Yes 
Fetched your folder for you  Not really Sometimes  Yes 
Assisted you when you were lost or overwhelmed 






Would you like this role of co-ordinator to continue at the clinic? 
No Not really Maybe Yes Definitely 
     
 
The visit to the doctor: 
Do you remember which doctor you saw since you joined Abundant Life? 
Yes       No 
If yes, which doctor was it? _____________________________________ 
Did the doctor explain what is wrong with you? 
Yes       No 
Did the doctor answer your questions? 
No Not really Mostly Yes All of them 
     
Did the doctor try to make you feel better? 
No Not really He/she tried Yes He/she made a 
difference 
     
Did the doctor try to improve your quality of life? 
No Not really He/she tried Yes He/she made a 
difference 
     
How helpful was that discussion to how you are feeling now? 
Not helpful A little bit It helped It helped alot It made a big 
difference  







Did you attend any of the support group sessions? 
Yes       No 
If yes, how many?  _______ 
If no, was there any reason?  _______________________________________________ 
If you attended any of the support group sessions, would you like to see them continue? 
Yes       No 
If yes, what aspects were helpful to you? 
Getting out the house  Not the reason I came  Sometimes Definitely 
Meeting new people  Not the reason I came  Sometimes Definitely 
Drinking the tea and coffee Not the reason I came  Sometimes Definitely 
Meeting people who have similar problems to me 
    Not the reason I came  Sometimes Definitely 
Just nice to talk   Not the reason I came  Sometimes Definitely 
The guest speakers  Not the reason I came  Sometimes Definitely 
Being able to support each other     
Not the reason I came  Sometimes Definitely  
The information I received in the sessions 
    Not the reason I came  Sometimes Definitely 
 
If you would not like the support group to continue, why? 
__________________________________________________________________________
__________________________________________________________________________ 







If you would like it to continue, what venue would be best for you? 
 Yes No 
The current venue – at the 
clinic 
  
In the community, closer to 
your home?   
  
 
If you would like it to continue, how often would you like to meet? 
Now and then Every 2 months Every month Every 2 weeks Weekly 
     
 
Overall: 
Looking at the whole programme, the co-ordinator, the doctor’s visit and the support group, 
would you like it to continue or stop? 
Continue      Stop 
Should there be any changes? 
Yes       No 
If yes, what changes?  
__________________________________________________________________________
__________________________________________________________________________ 
Have you recommended the programme to others? 
Yes       No 
Would you recommend the programme to others?  
Yes       No 
Thank you for your time. 
Enjoy the rest of your day! 
 





Abundant Life Programme Evaluation 
Staff 
Please tick the appropriate block, or the block that best answers how you feel. 
Role in the clinic: 
Doctor      CNP 
RN      EN 
ENA      HPO 
Admin      Other ____________________________ 
Do you know about the Abundant Life Research project? Yes   No 
Have you been involved with it?     Yes   No 
If yes, in what ways? 
As a patient/family 
Referred patients to the programme 
Seen patients as part of the programme 
Assisted the co-ordinator with a query 
Attended a support group 
   
Have you referred a patient to the programme?   Yes   No 
Did you know which patients to refer?    Yes   No 
Did you feel there were barriers to referral to the programme? Yes   No 
If so, what barriers were there? 
__________________________________________________________________________ 
__________________________________________________________________________ 
Have you met the Abundant Life Co-ordinator?  Yvonne?  Yes   No 
Have you asked Yvonne to assist you with patient care, of patients not necessarily in the 





What impact has this programme had on you? 








Would you like to be more involved in the programme, if it were to continue?  
Yes   No 
Would you like more information on the programme?   Yes   No 
Would you like more palliative care training for yourself?  Yes   No 
 
 
Thank you for your time. 
Enjoy the rest of your day! 
 











Appendix F:  
A Study of the Abundant Life Programme at Mitchells Plain Community Health 
Centre: Support for people with chronic illnesses 
General Patient Information sheet: 
Dear Sir/Madam,  
Thank you for allowing me to tell you about a study I am conducting at Mitchells Plain 
Community Health Centre.  
My name is Jennie Morgan and I am currently doing my Master’s Degree in Family 
Medicine with the University of Cape Town. As a masters student I need to conduct research 
that will improve the care of patients at a primary health care level. I have chosen to focus on 
people who are facing life-threatening illnesses and their families. I would like to implement 
a service to improve their quality of life.  
This information sheet will explain the study to you. Please ask any questions you may have. 
Please take your time in deciding whether or not you would like to join the study.  
What is the purpose of this study?  
We are looking at introducing a new service at MPCHC, called Abundant Life. We would 
like to see whether this service is of benefit to you and your family.  
What is Abundant Life?  
Abundant Life is a programme for people who are in need of palliative care. Palliative care is 
the care of a person who has a serious and progressive illness and for whom there is no 
expectation of a cure. This includes the physical, mental, social and spiritual parts of their 
care. The aim of the Abundant Life programme is to enable the patient to remain at home as 
part of the family for as long and as comfortable as possible. Abundant Life also aims to 
assist the people caring for the patient to do so with confidence and competence.  
Why are you being approached?  
Your doctor or clinical nurse practitioner has identified that your illness is progressive and 
that there is no expectation of cure. Thus you have now reached the point of needing 
palliative care. This study will evaluate the extent of people at MP CHC in need of palliative 
care and evaluate a possible programme, for its effectiveness for you and your family.  
 Do I have to take part in this study?  
NO, you do not have to take part in this study. Participation in this study is voluntary and 
will in no way change your care at this clinic. If you join this study, you can withdraw from 
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it at any point and it will not change how you are cared for at this clinic. If you decide to 
join, I will ask you to sign a consent form to say you understand what I am asking of you. 
You may want to think this over and talk to your family. Please feel free to do so.  
What will happen if I take part in this study?  
I will ask you eight questions about you and your health. I will ask four question of your care 
giver, as well. This should take about five to ten minutes of your time. You will be invited to 
join a support group here at the CHC, which will be run fortnightly, every alternate Monday 
at 1pm. If you join the study you will be informed when the support group is starting, as it 
will not be starting immediately. Attendance at the support group is not compulsory, and will 
in no way affect your care or participation in the study. The support group will run for 
approximately three months. If it is found to be beneficial, plans will be made for it to 
continue after the completion of the study. At this point you would be agreeing to join the 
programme for three months. We would like to try this programme out with a small group of 
people first. We would be grateful if you would assist us by participating.   At the end of the 
programme we will ask you to complete an evaluation form, to assist us in getting your 
feedback on how helpful the programme was to you and your family. 
Group A and B:  
Some participants may be asked to become more involved in the study. This will entail being 
asked questions on your health and symptoms of your disease each week for six weeks. Each 
week you will be asked seven questions. And a member of your family, if they give consent, 
will be asked three questions weekly for six weeks. We are not asking everyone to be part of 
these groups, as we only need a small number of people to answer these questions for the 
study.  
Direct Benefits of the study  
There will not necessarily be any direct benefits of the study to each participant. You may 
find that the questions asked bring up points you would like to raise with your clinician or 
family. The goal of the study is to find out whether this service is beneficial to the clients of 
our Community Health Centre.  
Risks of this study  
You might find the questions helpful in bringing up issues you may want to deal with, the 
questions may cause you or your family distress. If any of the questions cause you distress 
you may withdraw from the study at any point. Your care will still continue as before from 




Will the information you provide be kept confidential?  
All the information you give during the interview will be kept strictly confidential. No one 
outside this study will have direct access to the information you give. The personal 
information you give, your name and age will be kept separate from the interview 
information. A number will be used to indicate to myself that it is your information from an 
interview. No name will appear on each interview sheet.  
I will also ask your permission to interview a member of the family who may be currently 
caring for you, or close to you. If you give permission, I will ask their permission to ask 
them questions. If they decline to be involved, that will not affect your involvement in the 
study. This information that they give me will be kept in strict confidence between me and 
them. It will not be revealed to you or the rest of the family.  
Nothing you say in the interview will be relayed to your clinician or family. It will be up to 
you to raise any issues with your clinician or family.  
How will I know about the results of the study?  
At the end of the study a report stating the results of the study will be given to the CHC and 
available for the participants of the study at the Community Health Centre.  
If you need to talk to anyone with regard to this research, please call:  
Dr Jennie Morgan 0823900402  
Faculty of Health Sciences: Human Research Ethics Committee. Mrs Lamees Emjedi  
Research Ethics Committee  
E 52 Room 24, Old Main Building, Groote Schuur Hospital, Observatory  













I have read the information sheet and understand the information sheet. I have had the 
opportunity to ask any questions I may have.  
I understand that this study is voluntary and I can withdraw at any point, without giving a 
reason, and my care will not be compromised.  
I agree to take part in the study.  
Name: _____________________ Date: __________________  
Signature: ___________________________  
Researcher:  Signature: _______________________ Date: _________________  
Witness: Name: __________________________ Date: _________________  
Signature: _______________________  
109 
 
Appendix G:  
A Study of the Abundant Life Programme at Mitchells Plain Community Health 
Centre: Support for people with chronic illnesses 
Specific Information sheet for Group A and B: 
Dear Sir/Madam,  
Thank you for joining our study. We would like to invite you and your care giver to join a 
more intensive part of this study. Please allow me to explain.  
What is the purpose of this intensive part of the study?  
We are looking at introducing a new service at MPCHC, called Abundant Life. Firstly we 
would like to evaluate how patients who are in need of palliative care are managing. We 
would like to evaluate your symptoms and some specific areas of your life that your disease 
may affect. That will be evaluated amongst Group A participants, before we start the 
Abundant Life programme. After we start the Abundant Life programme, Group B 
participants will be invited to join the Abundant Life programme and evaluated in the same 
way as Group A. Group A participants will also be introduced to the Abundant Life 
programme, but will not be asked the questions again.  
How do we decide who is in Group A or Group B?  
This decision is based on when you enter the programme. The first patients to enter the 
programme will be asked to join Group A. Once that group is full, patients will be asked to 
join Group B.  
You are being invited to join:  
    
Do I have to take part in this part of the study?  
NO, you do not have to take part in this part of the study. Participation in this study and this 
part of the study is voluntary and will in no way change your care at this clinic. If you join 
this part of the study, you can withdraw from it at any point and this will not change how 
you are cared for at this clinic. If you decide to join, I will ask you to sign a consent form to 
say you understand what I am asking of you. You may want to think this over and talk to 
your family. Please feel free to do so.  
What will happen if I take part in this part of the study?  
You will be placed, by us, into Group A or B.  
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Group A will be asked seven questions, every week for six weeks. These questions will be 
about your health, including questions on your symptoms and other problems you may have 
related to your illness. You will be asked to give us consent to ask questions of a member of 
your family. Your family member will be asked for consent to join the group. Then they will 
be asked three questions each week for six weeks. If your family member is not present or 
does not wish to participate in the study, that will not impact on your participation in the 
study.  
Group B will be asked to meet with a clinician to discuss your illness with you and your 
family. Then the questions, as asked of Group A will be asked of Group B. Participants in 
Group B will also be asked to give us consent to ask questions of a member of your family. 
That person will be asked to give us consent to join the study. If they give us consent, they 
will be asked three questions each week for six weeks. If they choose not to join the study, it 
will in no way impact on your involvement in the study.  
For each week of those six weeks the research assistant will call you by telephone, at a time 
convenient to you, to ask the questions. The questions will be asked in private and separately 
from the family member also involved in the study. This should take between six and ten 
minutes each week.  
At the start of Group B we will start to run a support group at MPCHC. This support group 
will run every second week, on Monday at 1pm. You will be informed when the support 
group is starting. All participants of the study will be invited. Attendance at the support 
group is not compulsory, and will in no way affect your care or participation in the study.  
At the end of the programme we will ask you to complete an evaluation form, to assist us in 
getting your feedback on how helpful the programme was to you and your family. 
Direct Benefits of the study 
There are not necessarily any direct benefits of the study to each participant. You may find 
that the questions asked bring up points you would like to raise with your clinician or family. 
The goal of the study is to find out whether this service is beneficial to the clients of our 
Community Health Centre.  
Risks of this study 
You might find the questions helpful in bringing up issues you may want to deal with, the 
questions may cause you or your family distress. If any of the questions cause you distress 
you may withdraw from the study at any point. Your care will still continue as before from 
the Community Health Centre and you will receive counselling as you need it.  
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Will this study be kept confidential? 
All the information you give in the interview will be kept strictly confidential. No one 
outside this study will have direct access to the information you give us. The personal 
information you give us, your name and age will be kept separate from the interview 
information, a number will be used to indicate to us that it is your information from an 
interview. No name will appear on each interview sheet.  
We will also ask your permission to interview a care giver who is currently caring for you. 
You and the family member involved in the study, will be interviewed separately and 
privately. This information that they give us will be kept in strict confidence and will not be 
revealed to the family member involved in the study, your family or your clinician. It will be 
up to you to raise any issues with your family or clinician.  
How will I know about the results of the study? 
At the end of the study a report stating the results of the study will be given to the CHC and 
available for the participants of the study at the Community Health Centre.  
If you need to talk to anyone with regard to this research, please call:  
Dr Jennie Morgan 0823900402  
Faculty of Health Sciences: Human Research Ethics Committee. Mrs Lamees Emjedi 
Research Ethics Committee  
E 52 Room 24, Old Main Building, Groote Schuur Hospital, Observatory  
Telephone: 021 406 6338 25  
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Consent: 
I have read the information sheet and understand the information sheet. I have had the 
opportunity to ask any questions I may have.  
I understand that this study is voluntary and I can withdraw at any point, without giving a 
reason, and my care will not be compromised.  
I agree to take part in the study.  
Group A      Group B  
Name: _____________________ Date: __________________  
Signature: ___________________________  
Researcher:  Signature: _______________________ Date: _________________ 
Witness:  Name: __________________________ Date: _________________ 
Signature: _______________________  
Permission is given to approach my family member, ________________________________ 
To ask him/her to join the study.  
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Appendix H: 
A Study of the Abundant Life Programme at Mitchells Plain Community Health 
Centre: Support for people with chronic illnesses 
Letter to an invited Family member: 
Dear Sir/Madam 
Thank you for allowing me to tell you about a study I am conducting at Mitchells Plain 
Community Health Centre. The patient in your care has agreed to take part in the study and 
given us consent to invite you to take part in the study too.  
My name is Jennie Morgan and I am currently doing my Master’s Degree in Family 
Medicine with the University of Cape Town. As a masters student I need to conduct research 
that will improve the care of patients at a primary health care level. I have chosen to focus on 
people who are facing life-threatening illnesses and their families. I would like to implement 
a service to improve their quality of life.  
This information sheet will explain the study to you. Please ask any questions you may have. 
Please take your time in deciding whether or not you would like to join the study.  
What is the purpose of this study? 
We are looking at introducing a new service at MPCHC, called Abundant Life. We would 
like to see whether this service is of benefit to you and your family.  
What is Abundant Life? 
Abundant Life is a programme for people who are in need of palliative care. Palliative care is 
the care of a person who has a serious and progressive illness and for whom there is no 
expectation of a cure. This includes the physical, mental, social and spiritual parts of their 
care. The aim of the Abundant Life programme is to enable the patient to remain at home as 
part of the family for as long and as comfortable as possible. Abundant Life also aims to 
assist the people caring for the patient to do so with confidence and competence.  
Why are you being approached? 
Your family member has been identified by their doctor or clinical nurse practitioner as 
being in need of palliative care. That their illness is progressive and that there is no 
expectation of cure. This study will evaluate the patient’s symptoms and ways in which their 
disease impacts on their life. It will also look at a family member, at the understanding you 
have on your family member’s illness, your confidence at looking after him/her and the 
concern that the family has over the patient. To achieve that we are asking for your 
participation in the study.  
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Do I have to take part in this study? 
NO, you do not have to take part in this study. Participation in this study is voluntary and 
will in no way change your family member’s care at this clinic. If you join this study, you 
can withdraw from it at any point and it will not change how you and your family member is 
cared for at this clinic. If you decide to join, I will ask you to sign a consent form to say you 
understand what I am asking of you. You may want to think this over. Please feel free to do 
so.  
What will happen if I take part in this study? 
I will ask you to sign consent for us to involve you in the study. After that I will ask you 
three questions about your care of your family member. Then I will call the house each week 
for six weeks and ask the patient and yourself the questions again. This should take between 
six and ten minutes each week, at a time convenient to you.  
At the end of the programme we will ask you to complete an evaluation form, to assist us in 
getting your feedback on how helpful the programme was to you and your family. 
Direct Benefits of the study 
There will not necessarily be any direct benefits of the study to each participant. You may 
find that the questions asked bring up points you would like to raise with your family or the 
doctor. The goal of the study is to find out whether this service is beneficial to the clients of 
our Community Health Centre.  
Risks of this study 
You might find the questions helpful in bringing up issues you may want to deal with, the 
questions may cause you or your family distress. If any of the questions cause you distress 
you may withdraw from the study at any point. You and your family member’s care will still 
continue as before from the Community Health Centre and you will receive counselling as 
you need it.  
Will the information you provide be kept confidential? 
All the information you give me in the interview will be kept strictly confidential. No one 
outside this study will have direct access to the information you give me. You will be 
interviewed separately from the patient and the information you give us will not be revealed 
to them by us. The information the patient gives us will also not be revealed to you, that will 
be kept in confidence.  
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The personal information you give me, your name and age will be kept separate from the 
interview information. A number will be used to indicate to myself that it is your information 
from an interview. No name will appear on each interview sheet.  
How will I know about the results of the study? 
At the end of the study a report stating the results of the study will be given to the CHC and 
available for the participants of the study at the Community Health Centre.  
If you need to talk to anyone with regard to this research, please call:  
Dr Jennie Morgan 0823900402  
Faculty of Health Sciences: Human Research Ethics Committee. Mrs Lamees Emjedi 
Research Ethics Committee  
E 52 Room 24, Old Main Building, Groote Schuur Hospital, Observatory  
Telephone: 021 406 6338 28  
116 
Consent for Family Member: 
I have read the information sheet and understand the information sheet. I have had the 
opportunity to ask any questions I may have.  
I understand that this study is voluntary and I can withdraw at any point, without giving a 
reason, and the care of the person in my care will not be compromised.  
I agree to take part in the study.  
Name: _____________________ Date: __________________ 
Signature: ___________________________  
Researcher:  
Signature: _______________________ Date: _________________ 
Witness: Name: __________________________ Date: _________________  
Signature: _______________________  
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Signature removed
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Signature removed
